| PF-4708671 |
ENSG00000031544.10 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| PF-4708671 |
ENSG00000088970.11 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| PF-4708671 |
ENSG00000099869.6 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| PF-4708671 |
ENSG00000117242.7 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| PF-4708671 |
ENSG00000118412.8 |
Predicted lncRNA |
Sarcoma |
|
| PF-4708671 |
ENSG00000118412.8 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| PF-4708671 |
ENSG00000132204.9 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| PF-4708671 |
ENSG00000157306.10 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PF-4708671 |
ENSG00000160336.10 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| PF-4708671 |
ENSG00000167912.5 |
Predicted lncRNA |
Brain lower grade glioma |
|
| PF-4708671 |
ENSG00000167912.5 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| PF-4708671 |
ENSG00000170161.6 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| PF-4708671 |
ENSG00000171889.3 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| PF-4708671 |
ENSG00000174171.4 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| PF-4708671 |
ENSG00000175611.7 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| PF-4708671 |
ENSG00000175699.8 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| PF-4708671 |
ENSG00000175701.6 |
Predicted lncRNA |
Sarcoma |
|
| PF-4708671 |
ENSG00000177112.3 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| PF-4708671 |
ENSG00000177406.4 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| PF-4708671 |
ENSG00000177640.11 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PF-4708671 |
ENSG00000177788.5 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| PF-4708671 |
ENSG00000177822.3 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| PF-4708671 |
ENSG00000178440.5 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| PF-4708671 |
ENSG00000178977.3 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| PF-4708671 |
ENSG00000179818.9 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| PF-4708671 |
ENSG00000179935.5 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| PF-4708671 |
ENSG00000182366.5 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| PF-4708671 |
ENSG00000182376.2 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| PF-4708671 |
ENSG00000182376.2 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| PF-4708671 |
ENSG00000184068.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| PF-4708671 |
ENSG00000185168.5 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| PF-4708671 |
ENSG00000185186.4 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| PF-4708671 |
ENSG00000185203.7 |
Predicted lncRNA |
Sarcoma |
|
| PF-4708671 |
ENSG00000185495.6 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| PF-4708671 |
ENSG00000185904.7 |
Predicted lncRNA |
Esophageal cancer |
|
| PF-4708671 |
ENSG00000185904.7 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| PF-4708671 |
ENSG00000185904.7 |
Predicted lncRNA |
Sarcoma |
|
| PF-4708671 |
ENSG00000186148.7 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| PF-4708671 |
ENSG00000186594.8 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| PF-4708671 |
ENSG00000187904.3 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| PF-4708671 |
ENSG00000188206.5 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| PF-4708671 |
ENSG00000188660.3 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| PF-4708671 |
ENSG00000188660.3 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| PF-4708671 |
ENSG00000188660.3 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| PF-4708671 |
ENSG00000188825.9 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| PF-4708671 |
ENSG00000188825.9 |
Predicted lncRNA |
Sarcoma |
|
| PF-4708671 |
ENSG00000189223.9 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| PF-4708671 |
ENSG00000196810.4 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| PF-4708671 |
ENSG00000197670.5 |
Predicted lncRNA |
Brain lower grade glioma |
|
| PF-4708671 |
ENSG00000197670.5 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PF-4708671 |
ENSG00000198106.7 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| PF-4708671 |
ENSG00000203321.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PF-4708671 |
ENSG00000203321.2 |
Predicted lncRNA |
Sarcoma |
|
| PF-4708671 |
ENSG00000203325.3 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PF-4708671 |
ENSG00000203327.2 |
Predicted lncRNA |
Esophageal cancer |
|
| PF-4708671 |
ENSG00000203364.2 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| PF-4708671 |
ENSG00000203496.4 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| PF-4708671 |
ENSG00000203709.5 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PF-4708671 |
ENSG00000203739.3 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| PF-4708671 |
ENSG00000204054.7 |
Predicted lncRNA |
Sarcoma |
|
| PF-4708671 |
ENSG00000204054.7 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| PF-4708671 |
ENSG00000204055.4 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| PF-4708671 |
ENSG00000204581.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| PF-4708671 |
ENSG00000204625.6 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| PF-4708671 |
ENSG00000204758.3 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| PF-4708671 |
ENSG00000204792.2 |
Predicted lncRNA |
Sarcoma |
|
| PF-4708671 |
ENSG00000204934.6 |
Predicted lncRNA |
Sarcoma |
|
| PF-4708671 |
ENSG00000205037.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| PF-4708671 |
ENSG00000205562.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PF-4708671 |
ENSG00000205662.2 |
Predicted lncRNA |
Esophageal cancer |
|
| PF-4708671 |
ENSG00000205663.5 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| PF-4708671 |
ENSG00000205890.3 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| PF-4708671 |
ENSG00000206113.3 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| PF-4708671 |
ENSG00000206176.5 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| PF-4708671 |
ENSG00000206417.4 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PF-4708671 |
ENSG00000206417.4 |
Predicted lncRNA |
Sarcoma |
|
| PF-4708671 |
ENSG00000206567.5 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| PF-4708671 |
ENSG00000206567.5 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| PF-4708671 |
ENSG00000212552.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| PF-4708671 |
ENSG00000213279.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| PF-4708671 |
ENSG00000213742.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| PF-4708671 |
ENSG00000213904.4 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| PF-4708671 |
ENSG00000213963.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| PF-4708671 |
ENSG00000213963.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PF-4708671 |
ENSG00000214049.6 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| PF-4708671 |
ENSG00000214407.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PF-4708671 |
ENSG00000214691.6 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PF-4708671 |
ENSG00000214770.2 |
Predicted lncRNA |
Sarcoma |
|
| PF-4708671 |
ENSG00000214773.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PF-4708671 |
ENSG00000214803.3 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| PF-4708671 |
ENSG00000214837.4 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PF-4708671 |
ENSG00000214970.4 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| PF-4708671 |
ENSG00000215023.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| PF-4708671 |
ENSG00000215246.4 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| PF-4708671 |
ENSG00000215304.3 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| PF-4708671 |
ENSG00000215304.3 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| PF-4708671 |
ENSG00000215386.6 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| PF-4708671 |
ENSG00000215417.6 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| PF-4708671 |
ENSG00000215424.5 |
Predicted lncRNA |
Esophageal cancer |
|
| PF-4708671 |
ENSG00000215533.4 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PF-4708671 |
ENSG00000215692.2 |
Predicted lncRNA |
Esophageal cancer |
|
| PF-4708671 |
ENSG00000215841.3 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| PF-4708671 |
ENSG00000215863.2 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| PF-4708671 |
ENSG00000215869.3 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| PF-4708671 |
ENSG00000215908.5 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| PF-4708671 |
ENSG00000218018.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| PF-4708671 |
ENSG00000223374.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| PF-4708671 |
ENSG00000223380.3 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| PF-4708671 |
ENSG00000223382.3 |
Predicted lncRNA |
Esophageal cancer |
|
| PF-4708671 |
ENSG00000223396.2 |
Predicted lncRNA |
Esophageal cancer |
|
| PF-4708671 |
ENSG00000223442.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| PF-4708671 |
ENSG00000223477.3 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| PF-4708671 |
ENSG00000223542.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| PF-4708671 |
ENSG00000223552.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PF-4708671 |
ENSG00000223711.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| PF-4708671 |
ENSG00000223714.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| PF-4708671 |
ENSG00000223714.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| PF-4708671 |
ENSG00000223725.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PF-4708671 |
ENSG00000223734.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PF-4708671 |
ENSG00000223734.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| PF-4708671 |
ENSG00000223751.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PF-4708671 |
ENSG00000223759.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PF-4708671 |
ENSG00000223764.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| PF-4708671 |
ENSG00000223784.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| PF-4708671 |
ENSG00000223791.1 |
Predicted lncRNA |
Esophageal cancer |
|
| PF-4708671 |
ENSG00000223804.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| PF-4708671 |
ENSG00000223813.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PF-4708671 |
ENSG00000223815.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PF-4708671 |
ENSG00000223829.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| PF-4708671 |
ENSG00000223882.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| PF-4708671 |
ENSG00000223935.1 |
Predicted lncRNA |
Sarcoma |
|
| PF-4708671 |
ENSG00000223975.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| PF-4708671 |
ENSG00000224020.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| PF-4708671 |
ENSG00000224046.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| PF-4708671 |
ENSG00000224057.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| PF-4708671 |
ENSG00000224078.8 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| PF-4708671 |
ENSG00000224086.3 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| PF-4708671 |
ENSG00000224100.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| PF-4708671 |
ENSG00000224138.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| PF-4708671 |
ENSG00000224218.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| PF-4708671 |
ENSG00000224356.3 |
Predicted lncRNA |
Sarcoma |
|
| PF-4708671 |
ENSG00000224429.3 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| PF-4708671 |
ENSG00000224490.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| PF-4708671 |
ENSG00000224505.2 |
Predicted lncRNA |
Sarcoma |
|
| PF-4708671 |
ENSG00000224533.3 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| PF-4708671 |
ENSG00000224536.1 |
Predicted lncRNA |
Esophageal cancer |
|
| PF-4708671 |
ENSG00000224541.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| PF-4708671 |
ENSG00000224606.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| PF-4708671 |
ENSG00000224614.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| PF-4708671 |
ENSG00000224623.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| PF-4708671 |
ENSG00000224790.1 |
Predicted lncRNA |
Esophageal cancer |
|
| PF-4708671 |
ENSG00000224794.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| PF-4708671 |
ENSG00000224821.5 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| PF-4708671 |
ENSG00000224844.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PF-4708671 |
ENSG00000224844.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| PF-4708671 |
ENSG00000224885.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| PF-4708671 |
ENSG00000224897.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PF-4708671 |
ENSG00000224969.1 |
Predicted lncRNA |
Esophageal cancer |
|
| PF-4708671 |
ENSG00000224975.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| PF-4708671 |
ENSG00000224977.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| PF-4708671 |
ENSG00000225057.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| PF-4708671 |
ENSG00000225064.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PF-4708671 |
ENSG00000225163.3 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| PF-4708671 |
ENSG00000225195.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PF-4708671 |
ENSG00000225213.2 |
Predicted lncRNA |
Esophageal cancer |
|
| PF-4708671 |
ENSG00000225234.1 |
Predicted lncRNA |
Esophageal cancer |
|
| PF-4708671 |
ENSG00000225234.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| PF-4708671 |
ENSG00000225269.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PF-4708671 |
ENSG00000225285.1 |
Predicted lncRNA |
Sarcoma |
|
| PF-4708671 |
ENSG00000225292.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PF-4708671 |
ENSG00000225361.3 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PF-4708671 |
ENSG00000225411.2 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| PF-4708671 |
ENSG00000225442.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| PF-4708671 |
ENSG00000225457.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PF-4708671 |
ENSG00000225489.2 |
Predicted lncRNA |
Esophageal cancer |
|
| PF-4708671 |
ENSG00000225489.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PF-4708671 |
ENSG00000225521.1 |
Predicted lncRNA |
Sarcoma |
|
| PF-4708671 |
ENSG00000225548.1 |
Predicted lncRNA |
Esophageal cancer |
|
| PF-4708671 |
ENSG00000225555.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| PF-4708671 |
ENSG00000225555.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| PF-4708671 |
ENSG00000225751.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| PF-4708671 |
ENSG00000225764.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| PF-4708671 |
ENSG00000225783.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| PF-4708671 |
ENSG00000225793.2 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| PF-4708671 |
ENSG00000225794.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| PF-4708671 |
ENSG00000225798.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| PF-4708671 |
ENSG00000225798.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PF-4708671 |
ENSG00000225807.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PF-4708671 |
ENSG00000225839.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PF-4708671 |
ENSG00000225889.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PF-4708671 |
ENSG00000225891.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| PF-4708671 |
ENSG00000225963.3 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| PF-4708671 |
ENSG00000225978.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| PF-4708671 |
ENSG00000225986.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PF-4708671 |
ENSG00000226007.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| PF-4708671 |
ENSG00000226009.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| PF-4708671 |
ENSG00000226029.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PF-4708671 |
ENSG00000226029.1 |
Predicted lncRNA |
Sarcoma |
|
| PF-4708671 |
ENSG00000226047.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| PF-4708671 |
ENSG00000226067.2 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| PF-4708671 |
ENSG00000226087.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| PF-4708671 |
ENSG00000226113.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PF-4708671 |
ENSG00000226179.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PF-4708671 |
ENSG00000226245.1 |
Predicted lncRNA |
Sarcoma |
|
| PF-4708671 |
ENSG00000226251.1 |
Predicted lncRNA |
Sarcoma |
|
| PF-4708671 |
ENSG00000226291.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| PF-4708671 |
ENSG00000226310.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| PF-4708671 |
ENSG00000226332.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| PF-4708671 |
ENSG00000226332.2 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| PF-4708671 |
ENSG00000226332.2 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| PF-4708671 |
ENSG00000226380.3 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| PF-4708671 |
ENSG00000226380.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PF-4708671 |
ENSG00000226380.3 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PF-4708671 |
ENSG00000226386.1 |
Predicted lncRNA |
Esophageal cancer |
|
| PF-4708671 |
ENSG00000226416.1 |
Predicted lncRNA |
Esophageal cancer |
|
| PF-4708671 |
ENSG00000226419.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| PF-4708671 |
ENSG00000226440.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PF-4708671 |
ENSG00000226465.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| PF-4708671 |
ENSG00000226471.2 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| PF-4708671 |
ENSG00000226471.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PF-4708671 |
ENSG00000226637.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| PF-4708671 |
ENSG00000226690.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| PF-4708671 |
ENSG00000226746.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| PF-4708671 |
ENSG00000226754.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| PF-4708671 |
ENSG00000226756.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| PF-4708671 |
ENSG00000226798.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PF-4708671 |
ENSG00000226824.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| PF-4708671 |
ENSG00000226852.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| PF-4708671 |
ENSG00000226853.2 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| PF-4708671 |
ENSG00000226869.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| PF-4708671 |
ENSG00000226904.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| PF-4708671 |
ENSG00000226913.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| PF-4708671 |
ENSG00000226913.1 |
Predicted lncRNA |
Esophageal cancer |
|
| PF-4708671 |
ENSG00000226950.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PF-4708671 |
ENSG00000226965.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| PF-4708671 |
ENSG00000226985.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| PF-4708671 |
ENSG00000227014.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| PF-4708671 |
ENSG00000227068.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PF-4708671 |
ENSG00000227070.1 |
Predicted lncRNA |
Sarcoma |
|
| PF-4708671 |
ENSG00000227070.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| PF-4708671 |
ENSG00000227076.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PF-4708671 |
ENSG00000227076.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| PF-4708671 |
ENSG00000227165.3 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| PF-4708671 |
ENSG00000227188.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| PF-4708671 |
ENSG00000227195.4 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| PF-4708671 |
ENSG00000227214.2 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| PF-4708671 |
ENSG00000227356.2 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| PF-4708671 |
ENSG00000227356.2 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| PF-4708671 |
ENSG00000227372.6 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PF-4708671 |
ENSG00000227388.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| PF-4708671 |
ENSG00000227388.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| PF-4708671 |
ENSG00000227388.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PF-4708671 |
ENSG00000227477.1 |
Predicted lncRNA |
Sarcoma |
|
| PF-4708671 |
ENSG00000227502.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| PF-4708671 |
ENSG00000227502.2 |
Predicted lncRNA |
Esophageal cancer |
|
| PF-4708671 |
ENSG00000227544.4 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PF-4708671 |
ENSG00000227598.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| PF-4708671 |
ENSG00000227617.4 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| PF-4708671 |
ENSG00000227627.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| PF-4708671 |
ENSG00000227673.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| PF-4708671 |
ENSG00000227678.3 |
Predicted lncRNA |
Esophageal cancer |
|
| PF-4708671 |
ENSG00000227695.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| PF-4708671 |
ENSG00000227704.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| PF-4708671 |
ENSG00000227740.1 |
Predicted lncRNA |
Sarcoma |
|
| PF-4708671 |
ENSG00000227803.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PF-4708671 |
ENSG00000227811.2 |
Predicted lncRNA |
Esophageal cancer |
|
| PF-4708671 |
ENSG00000227908.3 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| PF-4708671 |
ENSG00000227938.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PF-4708671 |
ENSG00000227946.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| PF-4708671 |
ENSG00000228065.6 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| PF-4708671 |
ENSG00000228106.1 |
Predicted lncRNA |
Sarcoma |
|
| PF-4708671 |
ENSG00000228113.3 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| PF-4708671 |
ENSG00000228192.3 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| PF-4708671 |
ENSG00000228294.2 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| PF-4708671 |
ENSG00000228302.2 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| PF-4708671 |
ENSG00000228302.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PF-4708671 |
ENSG00000228323.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| PF-4708671 |
ENSG00000228327.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PF-4708671 |
ENSG00000228352.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PF-4708671 |
ENSG00000228363.2 |
Predicted lncRNA |
Sarcoma |
|
| PF-4708671 |
ENSG00000228386.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| PF-4708671 |
ENSG00000228395.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PF-4708671 |
ENSG00000228412.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| PF-4708671 |
ENSG00000228412.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| PF-4708671 |
ENSG00000228478.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| PF-4708671 |
ENSG00000228526.2 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| PF-4708671 |
ENSG00000228544.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| PF-4708671 |
ENSG00000228544.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PF-4708671 |
ENSG00000228573.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| PF-4708671 |
ENSG00000228573.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| PF-4708671 |
ENSG00000228661.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| PF-4708671 |
ENSG00000228719.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| PF-4708671 |
ENSG00000228742.5 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| PF-4708671 |
ENSG00000228742.5 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PF-4708671 |
ENSG00000228791.3 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| PF-4708671 |
ENSG00000228809.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| PF-4708671 |
ENSG00000228817.3 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PF-4708671 |
ENSG00000228838.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| PF-4708671 |
ENSG00000228917.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| PF-4708671 |
ENSG00000229017.2 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| PF-4708671 |
ENSG00000229122.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| PF-4708671 |
ENSG00000229152.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PF-4708671 |
ENSG00000229153.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| PF-4708671 |
ENSG00000229153.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| PF-4708671 |
ENSG00000229154.1 |
Predicted lncRNA |
Sarcoma |
|
| PF-4708671 |
ENSG00000229154.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| PF-4708671 |
ENSG00000229167.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| PF-4708671 |
ENSG00000229180.4 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PF-4708671 |
ENSG00000229190.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| PF-4708671 |
ENSG00000229308.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| PF-4708671 |
ENSG00000229325.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| PF-4708671 |
ENSG00000229368.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| PF-4708671 |
ENSG00000229368.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| PF-4708671 |
ENSG00000229401.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| PF-4708671 |
ENSG00000229401.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| PF-4708671 |
ENSG00000229425.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PF-4708671 |
ENSG00000229463.2 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| PF-4708671 |
ENSG00000229487.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| PF-4708671 |
ENSG00000229487.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| PF-4708671 |
ENSG00000229558.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| PF-4708671 |
ENSG00000229587.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PF-4708671 |
ENSG00000229589.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| PF-4708671 |
ENSG00000229589.1 |
Predicted lncRNA |
Esophageal cancer |
|
| PF-4708671 |
ENSG00000229591.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| PF-4708671 |
ENSG00000229618.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| PF-4708671 |
ENSG00000229647.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| PF-4708671 |
ENSG00000229647.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| PF-4708671 |
ENSG00000229647.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| PF-4708671 |
ENSG00000229647.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PF-4708671 |
ENSG00000229692.3 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| PF-4708671 |
ENSG00000229692.3 |
Predicted lncRNA |
Sarcoma |
|
| PF-4708671 |
ENSG00000229697.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| PF-4708671 |
ENSG00000229728.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| PF-4708671 |
ENSG00000229801.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| PF-4708671 |
ENSG00000229841.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| PF-4708671 |
ENSG00000229869.1 |
Predicted lncRNA |
Esophageal cancer |
|
| PF-4708671 |
ENSG00000229918.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PF-4708671 |
ENSG00000229931.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| PF-4708671 |
ENSG00000229931.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| PF-4708671 |
ENSG00000229941.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| PF-4708671 |
ENSG00000229950.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| PF-4708671 |
ENSG00000229951.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PF-4708671 |
ENSG00000229989.3 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PF-4708671 |
ENSG00000230005.2 |
Predicted lncRNA |
Sarcoma |
|
| PF-4708671 |
ENSG00000230021.3 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PF-4708671 |
ENSG00000230065.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| PF-4708671 |
ENSG00000230082.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| PF-4708671 |
ENSG00000230091.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| PF-4708671 |
ENSG00000230105.1 |
Predicted lncRNA |
Sarcoma |
|
| PF-4708671 |
ENSG00000230176.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| PF-4708671 |
ENSG00000230184.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| PF-4708671 |
ENSG00000230186.3 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| PF-4708671 |
ENSG00000230257.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PF-4708671 |
ENSG00000230266.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| PF-4708671 |
ENSG00000230323.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PF-4708671 |
ENSG00000230337.1 |
Predicted lncRNA |
Esophageal cancer |
|
| PF-4708671 |
ENSG00000230345.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| PF-4708671 |
ENSG00000230417.6 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| PF-4708671 |
ENSG00000230417.6 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| PF-4708671 |
ENSG00000230424.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| PF-4708671 |
ENSG00000230424.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| PF-4708671 |
ENSG00000230424.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| PF-4708671 |
ENSG00000230454.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| PF-4708671 |
ENSG00000230461.4 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| PF-4708671 |
ENSG00000230479.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| PF-4708671 |
ENSG00000230513.1 |
Predicted lncRNA |
Esophageal cancer |
|
| PF-4708671 |
ENSG00000230534.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| PF-4708671 |
ENSG00000230537.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PF-4708671 |
ENSG00000230569.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PF-4708671 |
ENSG00000230612.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| PF-4708671 |
ENSG00000230641.1 |
Predicted lncRNA |
Sarcoma |
|
| PF-4708671 |
ENSG00000230658.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| PF-4708671 |
ENSG00000230658.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PF-4708671 |
ENSG00000230658.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| PF-4708671 |
ENSG00000230684.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PF-4708671 |
ENSG00000230812.1 |
Predicted lncRNA |
Sarcoma |
|
| PF-4708671 |
ENSG00000230815.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PF-4708671 |
ENSG00000230825.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| PF-4708671 |
ENSG00000230836.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PF-4708671 |
ENSG00000230914.2 |
Predicted lncRNA |
Esophageal cancer |
|
| PF-4708671 |
ENSG00000230918.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PF-4708671 |
ENSG00000230925.3 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| PF-4708671 |
ENSG00000230939.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| PF-4708671 |
ENSG00000230990.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PF-4708671 |
ENSG00000231010.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| PF-4708671 |
ENSG00000231010.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| PF-4708671 |
ENSG00000231028.4 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| PF-4708671 |
ENSG00000231050.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| PF-4708671 |
ENSG00000231064.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| PF-4708671 |
ENSG00000231081.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| PF-4708671 |
ENSG00000231105.1 |
Predicted lncRNA |
Esophageal cancer |
|
| PF-4708671 |
ENSG00000231107.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| PF-4708671 |
ENSG00000231113.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PF-4708671 |
ENSG00000231119.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| PF-4708671 |
ENSG00000231125.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| PF-4708671 |
ENSG00000231131.2 |
Predicted lncRNA |
Sarcoma |
|
| PF-4708671 |
ENSG00000231133.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| PF-4708671 |
ENSG00000231154.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| PF-4708671 |
ENSG00000231156.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PF-4708671 |
ENSG00000231172.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| PF-4708671 |
ENSG00000231188.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| PF-4708671 |
ENSG00000231242.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PF-4708671 |
ENSG00000231242.1 |
Predicted lncRNA |
Sarcoma |
|
| PF-4708671 |
ENSG00000231249.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| PF-4708671 |
ENSG00000231272.1 |
Predicted lncRNA |
Esophageal cancer |
|
| PF-4708671 |
ENSG00000231273.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| PF-4708671 |
ENSG00000231298.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PF-4708671 |
ENSG00000231305.3 |
Predicted lncRNA |
Esophageal cancer |
|
| PF-4708671 |
ENSG00000231346.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| PF-4708671 |
ENSG00000231346.1 |
Predicted lncRNA |
Esophageal cancer |
|
| PF-4708671 |
ENSG00000231355.1 |
Predicted lncRNA |
Esophageal cancer |
|
| PF-4708671 |
ENSG00000231363.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| PF-4708671 |
ENSG00000231393.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PF-4708671 |
ENSG00000231465.2 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| PF-4708671 |
ENSG00000231512.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| PF-4708671 |
ENSG00000231551.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| PF-4708671 |
ENSG00000231563.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| PF-4708671 |
ENSG00000231611.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| PF-4708671 |
ENSG00000231612.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| PF-4708671 |
ENSG00000231616.4 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PF-4708671 |
ENSG00000231628.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| PF-4708671 |
ENSG00000231628.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| PF-4708671 |
ENSG00000231628.1 |
Predicted lncRNA |
Sarcoma |
|
| PF-4708671 |
ENSG00000231651.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| PF-4708671 |
ENSG00000231652.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PF-4708671 |
ENSG00000231703.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PF-4708671 |
ENSG00000231704.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| PF-4708671 |
ENSG00000231709.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| PF-4708671 |
ENSG00000231731.3 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PF-4708671 |
ENSG00000231734.4 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| PF-4708671 |
ENSG00000231808.1 |
Predicted lncRNA |
Esophageal cancer |
|
| PF-4708671 |
ENSG00000231816.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PF-4708671 |
ENSG00000231817.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PF-4708671 |
ENSG00000231830.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PF-4708671 |
ENSG00000231842.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| PF-4708671 |
ENSG00000231856.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PF-4708671 |
ENSG00000231881.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| PF-4708671 |
ENSG00000231881.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| PF-4708671 |
ENSG00000231908.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PF-4708671 |
ENSG00000231920.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| PF-4708671 |
ENSG00000231992.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PF-4708671 |
ENSG00000232019.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| PF-4708671 |
ENSG00000232043.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| PF-4708671 |
ENSG00000232053.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| PF-4708671 |
ENSG00000232082.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PF-4708671 |
ENSG00000232098.2 |
Predicted lncRNA |
Esophageal cancer |
|
| PF-4708671 |
ENSG00000232116.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PF-4708671 |
ENSG00000232160.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| PF-4708671 |
ENSG00000232259.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PF-4708671 |
ENSG00000232300.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| PF-4708671 |
ENSG00000232325.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PF-4708671 |
ENSG00000232342.3 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| PF-4708671 |
ENSG00000232352.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| PF-4708671 |
ENSG00000232352.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PF-4708671 |
ENSG00000232377.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| PF-4708671 |
ENSG00000232386.5 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PF-4708671 |
ENSG00000232388.2 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| PF-4708671 |
ENSG00000232485.2 |
Predicted lncRNA |
Esophageal cancer |
|
| PF-4708671 |
ENSG00000232485.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| PF-4708671 |
ENSG00000232533.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| PF-4708671 |
ENSG00000232564.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| PF-4708671 |
ENSG00000232586.1 |
Predicted lncRNA |
Esophageal cancer |
|
| PF-4708671 |
ENSG00000232613.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PF-4708671 |
ENSG00000232628.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PF-4708671 |
ENSG00000232640.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| PF-4708671 |
ENSG00000232645.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| PF-4708671 |
ENSG00000232655.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PF-4708671 |
ENSG00000232677.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PF-4708671 |
ENSG00000232692.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PF-4708671 |
ENSG00000232693.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| PF-4708671 |
ENSG00000232698.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PF-4708671 |
ENSG00000232710.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PF-4708671 |
ENSG00000232712.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| PF-4708671 |
ENSG00000232719.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| PF-4708671 |
ENSG00000232725.1 |
Predicted lncRNA |
Sarcoma |
|
| PF-4708671 |
ENSG00000232754.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| PF-4708671 |
ENSG00000232754.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| PF-4708671 |
ENSG00000232807.2 |
Predicted lncRNA |
Sarcoma |
|
| PF-4708671 |
ENSG00000232909.1 |
Predicted lncRNA |
Sarcoma |
|
| PF-4708671 |
ENSG00000232936.1 |
Predicted lncRNA |
Sarcoma |
|
| PF-4708671 |
ENSG00000232940.1 |
Predicted lncRNA |
Esophageal cancer |
|
| PF-4708671 |
ENSG00000232973.7 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| PF-4708671 |
ENSG00000233006.2 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| PF-4708671 |
ENSG00000233029.3 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| PF-4708671 |
ENSG00000233056.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| PF-4708671 |
ENSG00000233058.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PF-4708671 |
ENSG00000233069.1 |
Predicted lncRNA |
Sarcoma |
|
| PF-4708671 |
ENSG00000233080.2 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| PF-4708671 |
ENSG00000233081.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| PF-4708671 |
ENSG00000233110.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| PF-4708671 |
ENSG00000233137.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PF-4708671 |
ENSG00000233184.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| PF-4708671 |
ENSG00000233203.2 |
Predicted lncRNA |
Esophageal cancer |
|
| PF-4708671 |
ENSG00000233223.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PF-4708671 |
ENSG00000233230.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| PF-4708671 |
ENSG00000233237.2 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| PF-4708671 |
ENSG00000233244.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| PF-4708671 |
ENSG00000233246.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PF-4708671 |
ENSG00000233255.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| PF-4708671 |
ENSG00000233321.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PF-4708671 |
ENSG00000233355.2 |
Predicted lncRNA |
Esophageal cancer |
|
| PF-4708671 |
ENSG00000233360.4 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| PF-4708671 |
ENSG00000233368.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| PF-4708671 |
ENSG00000233427.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| PF-4708671 |
ENSG00000233461.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| PF-4708671 |
ENSG00000233483.2 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| PF-4708671 |
ENSG00000233496.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PF-4708671 |
ENSG00000233515.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| PF-4708671 |
ENSG00000233527.4 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PF-4708671 |
ENSG00000233547.1 |
Predicted lncRNA |
Sarcoma |
|
| PF-4708671 |
ENSG00000233602.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PF-4708671 |
ENSG00000233613.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| PF-4708671 |
ENSG00000233613.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PF-4708671 |
ENSG00000233672.2 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| PF-4708671 |
ENSG00000233718.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| PF-4708671 |
ENSG00000233799.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| PF-4708671 |
ENSG00000233818.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| PF-4708671 |
ENSG00000233825.1 |
Predicted lncRNA |
Esophageal cancer |
|
| PF-4708671 |
ENSG00000233825.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| PF-4708671 |
ENSG00000233844.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PF-4708671 |
ENSG00000233895.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PF-4708671 |
ENSG00000233967.2 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| PF-4708671 |
ENSG00000234006.1 |
Predicted lncRNA |
Esophageal cancer |
|
| PF-4708671 |
ENSG00000234006.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| PF-4708671 |
ENSG00000234026.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| PF-4708671 |
ENSG00000234070.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| PF-4708671 |
ENSG00000234076.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PF-4708671 |
ENSG00000234084.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| PF-4708671 |
ENSG00000234147.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| PF-4708671 |
ENSG00000234171.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| PF-4708671 |
ENSG00000234181.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PF-4708671 |
ENSG00000234199.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| PF-4708671 |
ENSG00000234222.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| PF-4708671 |
ENSG00000234222.2 |
Predicted lncRNA |
Sarcoma |
|
| PF-4708671 |
ENSG00000234230.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| PF-4708671 |
ENSG00000234233.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| PF-4708671 |
ENSG00000234252.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| PF-4708671 |
ENSG00000234264.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| PF-4708671 |
ENSG00000234264.1 |
Predicted lncRNA |
Esophageal cancer |
|
| PF-4708671 |
ENSG00000234290.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| PF-4708671 |
ENSG00000234380.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| PF-4708671 |
ENSG00000234509.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| PF-4708671 |
ENSG00000234509.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| PF-4708671 |
ENSG00000234630.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PF-4708671 |
ENSG00000234650.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| PF-4708671 |
ENSG00000234665.4 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| PF-4708671 |
ENSG00000234693.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PF-4708671 |
ENSG00000234753.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| PF-4708671 |
ENSG00000234789.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PF-4708671 |
ENSG00000234793.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| PF-4708671 |
ENSG00000234793.1 |
Predicted lncRNA |
Sarcoma |
|
| PF-4708671 |
ENSG00000234917.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PF-4708671 |
ENSG00000234945.3 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| PF-4708671 |
ENSG00000234945.3 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| PF-4708671 |
ENSG00000234978.1 |
Predicted lncRNA |
Esophageal cancer |
|
| PF-4708671 |
ENSG00000235092.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| PF-4708671 |
ENSG00000235100.3 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| PF-4708671 |
ENSG00000235106.4 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PF-4708671 |
ENSG00000235119.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| PF-4708671 |
ENSG00000235121.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| PF-4708671 |
ENSG00000235138.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| PF-4708671 |
ENSG00000235142.3 |
Predicted lncRNA |
Esophageal cancer |
|
| PF-4708671 |
ENSG00000235159.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| PF-4708671 |
ENSG00000235172.3 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| PF-4708671 |
ENSG00000235236.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| PF-4708671 |
ENSG00000235246.1 |
Predicted lncRNA |
Sarcoma |
|
| PF-4708671 |
ENSG00000235269.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| PF-4708671 |
ENSG00000235298.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| PF-4708671 |
ENSG00000235298.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PF-4708671 |
ENSG00000235373.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| PF-4708671 |
ENSG00000235373.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| PF-4708671 |
ENSG00000235373.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PF-4708671 |
ENSG00000235373.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| PF-4708671 |
ENSG00000235408.2 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| PF-4708671 |
ENSG00000235408.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| PF-4708671 |
ENSG00000235419.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| PF-4708671 |
ENSG00000235419.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| PF-4708671 |
ENSG00000235426.2 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| PF-4708671 |
ENSG00000235448.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| PF-4708671 |
ENSG00000235477.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| PF-4708671 |
ENSG00000235488.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| PF-4708671 |
ENSG00000235501.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| PF-4708671 |
ENSG00000235545.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| PF-4708671 |
ENSG00000235601.1 |
Predicted lncRNA |
Sarcoma |
|
| PF-4708671 |
ENSG00000235609.4 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| PF-4708671 |
ENSG00000235652.3 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| PF-4708671 |
ENSG00000235652.3 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| PF-4708671 |
ENSG00000235652.3 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| PF-4708671 |
ENSG00000235703.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| PF-4708671 |
ENSG00000235703.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PF-4708671 |
ENSG00000235770.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| PF-4708671 |
ENSG00000235795.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| PF-4708671 |
ENSG00000235831.2 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| PF-4708671 |
ENSG00000235884.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| PF-4708671 |
ENSG00000235897.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PF-4708671 |
ENSG00000235908.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PF-4708671 |
ENSG00000235927.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| PF-4708671 |
ENSG00000235927.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| PF-4708671 |
ENSG00000235934.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| PF-4708671 |
ENSG00000235958.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| PF-4708671 |
ENSG00000236017.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PF-4708671 |
ENSG00000236194.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PF-4708671 |
ENSG00000236204.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| PF-4708671 |
ENSG00000236266.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PF-4708671 |
ENSG00000236269.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| PF-4708671 |
ENSG00000236358.1 |
Predicted lncRNA |
Esophageal cancer |
|
| PF-4708671 |
ENSG00000236384.3 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| PF-4708671 |
ENSG00000236423.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| PF-4708671 |
ENSG00000236423.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| PF-4708671 |
ENSG00000236498.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PF-4708671 |
ENSG00000236514.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| PF-4708671 |
ENSG00000236519.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| PF-4708671 |
ENSG00000236519.1 |
Predicted lncRNA |
Esophageal cancer |
|
| PF-4708671 |
ENSG00000236526.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| PF-4708671 |
ENSG00000236536.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PF-4708671 |
ENSG00000236559.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| PF-4708671 |
ENSG00000236559.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| PF-4708671 |
ENSG00000236601.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| PF-4708671 |
ENSG00000236651.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| PF-4708671 |
ENSG00000236700.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| PF-4708671 |
ENSG00000236717.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| PF-4708671 |
ENSG00000236757.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PF-4708671 |
ENSG00000236772.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| PF-4708671 |
ENSG00000236842.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PF-4708671 |
ENSG00000236861.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| PF-4708671 |
ENSG00000236896.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| PF-4708671 |
ENSG00000236901.3 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| PF-4708671 |
ENSG00000236915.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PF-4708671 |
ENSG00000236961.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| PF-4708671 |
ENSG00000236983.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PF-4708671 |
ENSG00000237017.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| PF-4708671 |
ENSG00000237017.1 |
Predicted lncRNA |
Sarcoma |
|
| PF-4708671 |
ENSG00000237054.5 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| PF-4708671 |
ENSG00000237073.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| PF-4708671 |
ENSG00000237126.4 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PF-4708671 |
ENSG00000237181.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| PF-4708671 |
ENSG00000237184.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| PF-4708671 |
ENSG00000237187.4 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| PF-4708671 |
ENSG00000237188.3 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| PF-4708671 |
ENSG00000237208.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PF-4708671 |
ENSG00000237250.3 |
Predicted lncRNA |
Sarcoma |
|
| PF-4708671 |
ENSG00000237253.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| PF-4708671 |
ENSG00000237298.4 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| PF-4708671 |
ENSG00000237301.1 |
Predicted lncRNA |
Sarcoma |
|
| PF-4708671 |
ENSG00000237399.3 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PF-4708671 |
ENSG00000237413.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PF-4708671 |
ENSG00000237424.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| PF-4708671 |
ENSG00000237438.2 |
Predicted lncRNA |
Esophageal cancer |
|
| PF-4708671 |
ENSG00000237491.4 |
Predicted lncRNA |
Sarcoma |
|
| PF-4708671 |
ENSG00000237499.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PF-4708671 |
ENSG00000237520.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| PF-4708671 |
ENSG00000237587.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PF-4708671 |
ENSG00000237588.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PF-4708671 |
ENSG00000237689.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| PF-4708671 |
ENSG00000237689.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| PF-4708671 |
ENSG00000237689.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| PF-4708671 |
ENSG00000237714.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| PF-4708671 |
ENSG00000237738.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| PF-4708671 |
ENSG00000237756.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| PF-4708671 |
ENSG00000237798.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| PF-4708671 |
ENSG00000237807.3 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| PF-4708671 |
ENSG00000237807.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PF-4708671 |
ENSG00000237819.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| PF-4708671 |
ENSG00000237899.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| PF-4708671 |
ENSG00000237938.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| PF-4708671 |
ENSG00000237950.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| PF-4708671 |
ENSG00000237989.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| PF-4708671 |
ENSG00000237998.3 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| PF-4708671 |
ENSG00000238045.5 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PF-4708671 |
ENSG00000238120.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| PF-4708671 |
ENSG00000238133.2 |
Predicted lncRNA |
Esophageal cancer |
|
| PF-4708671 |
ENSG00000238142.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| PF-4708671 |
ENSG00000238164.2 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| PF-4708671 |
ENSG00000238184.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| PF-4708671 |
ENSG00000238186.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| PF-4708671 |
ENSG00000238197.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| PF-4708671 |
ENSG00000238260.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| PF-4708671 |
ENSG00000238260.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| PF-4708671 |
ENSG00000238273.3 |
Predicted lncRNA |
Sarcoma |
|
| PF-4708671 |
ENSG00000238273.3 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| PF-4708671 |
ENSG00000238358.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| PF-4708671 |
ENSG00000239353.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| PF-4708671 |
ENSG00000239353.1 |
Predicted lncRNA |
Sarcoma |
|
| PF-4708671 |
ENSG00000239377.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| PF-4708671 |
ENSG00000239523.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| PF-4708671 |
ENSG00000239653.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| PF-4708671 |
ENSG00000239906.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| PF-4708671 |
ENSG00000239906.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| PF-4708671 |
ENSG00000240015.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PF-4708671 |
ENSG00000240057.1 |
Predicted lncRNA |
Esophageal cancer |
|
| PF-4708671 |
ENSG00000240093.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| PF-4708671 |
ENSG00000240137.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PF-4708671 |
ENSG00000240143.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| PF-4708671 |
ENSG00000240350.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| PF-4708671 |
ENSG00000240498.2 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| PF-4708671 |
ENSG00000240541.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| PF-4708671 |
ENSG00000240571.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| PF-4708671 |
ENSG00000240571.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| PF-4708671 |
ENSG00000240591.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| PF-4708671 |
ENSG00000240875.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| PF-4708671 |
ENSG00000240990.5 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PF-4708671 |
ENSG00000241125.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PF-4708671 |
ENSG00000241280.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PF-4708671 |
ENSG00000241472.2 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| PF-4708671 |
ENSG00000241520.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| PF-4708671 |
ENSG00000241732.1 |
Predicted lncRNA |
Esophageal cancer |
|
| PF-4708671 |
ENSG00000241732.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PF-4708671 |
ENSG00000241770.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| PF-4708671 |
ENSG00000241770.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| PF-4708671 |
ENSG00000241818.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| PF-4708671 |
ENSG00000241818.1 |
Predicted lncRNA |
Sarcoma |
|
| PF-4708671 |
ENSG00000241860.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PF-4708671 |
ENSG00000241933.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| PF-4708671 |
ENSG00000242082.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| PF-4708671 |
ENSG00000242147.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| PF-4708671 |
ENSG00000242288.6 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PF-4708671 |
ENSG00000242396.1 |
Predicted lncRNA |
Esophageal cancer |
|
| PF-4708671 |
ENSG00000242516.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| PF-4708671 |
ENSG00000242516.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| PF-4708671 |
ENSG00000242578.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PF-4708671 |
ENSG00000242578.1 |
Predicted lncRNA |
Sarcoma |
|
| PF-4708671 |
ENSG00000242593.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PF-4708671 |
ENSG00000242611.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PF-4708671 |
ENSG00000242622.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| PF-4708671 |
ENSG00000242759.2 |
Predicted lncRNA |
Esophageal cancer |
|
| PF-4708671 |
ENSG00000242798.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| PF-4708671 |
ENSG00000242808.3 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| PF-4708671 |
ENSG00000243055.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| PF-4708671 |
ENSG00000243107.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| PF-4708671 |
ENSG00000243176.1 |
Predicted lncRNA |
Esophageal cancer |
|
| PF-4708671 |
ENSG00000243368.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| PF-4708671 |
ENSG00000243479.3 |
Predicted lncRNA |
Esophageal cancer |
|
| PF-4708671 |
ENSG00000243533.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| PF-4708671 |
ENSG00000243849.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| PF-4708671 |
ENSG00000243885.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| PF-4708671 |
ENSG00000243960.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| PF-4708671 |
ENSG00000244184.1 |
Predicted lncRNA |
Sarcoma |
|
| PF-4708671 |
ENSG00000244300.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| PF-4708671 |
ENSG00000244349.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| PF-4708671 |
ENSG00000244468.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| PF-4708671 |
ENSG00000244649.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PF-4708671 |
ENSG00000244879.3 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PF-4708671 |
ENSG00000244945.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PF-4708671 |
ENSG00000244968.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PF-4708671 |
ENSG00000245060.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| PF-4708671 |
ENSG00000245112.2 |
Predicted lncRNA |
Esophageal cancer |
|
| PF-4708671 |
ENSG00000245248.3 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| PF-4708671 |
ENSG00000245275.3 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| PF-4708671 |
ENSG00000245275.3 |
Predicted lncRNA |
Sarcoma |
|
| PF-4708671 |
ENSG00000245281.2 |
Predicted lncRNA |
Sarcoma |
|
| PF-4708671 |
ENSG00000245468.3 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| PF-4708671 |
ENSG00000245479.2 |
Predicted lncRNA |
Sarcoma |
|
| PF-4708671 |
ENSG00000245522.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PF-4708671 |
ENSG00000245556.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| PF-4708671 |
ENSG00000245571.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| PF-4708671 |
ENSG00000245614.2 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| PF-4708671 |
ENSG00000245667.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| PF-4708671 |
ENSG00000245694.4 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| PF-4708671 |
ENSG00000245928.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| PF-4708671 |
ENSG00000246130.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| PF-4708671 |
ENSG00000246174.3 |
Predicted lncRNA |
Esophageal cancer |
|
| PF-4708671 |
ENSG00000246228.2 |
Predicted lncRNA |
Sarcoma |
|
| PF-4708671 |
ENSG00000246263.2 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| PF-4708671 |
ENSG00000246331.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| PF-4708671 |
ENSG00000246334.2 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| PF-4708671 |
ENSG00000246375.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| PF-4708671 |
ENSG00000246422.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| PF-4708671 |
ENSG00000246451.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| PF-4708671 |
ENSG00000246548.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PF-4708671 |
ENSG00000246731.2 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| PF-4708671 |
ENSG00000246851.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PF-4708671 |
ENSG00000246859.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| PF-4708671 |
ENSG00000247095.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| PF-4708671 |
ENSG00000247134.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| PF-4708671 |
ENSG00000247151.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| PF-4708671 |
ENSG00000247228.2 |
Predicted lncRNA |
Esophageal cancer |
|
| PF-4708671 |
ENSG00000247271.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| PF-4708671 |
ENSG00000247373.2 |
Predicted lncRNA |
Sarcoma |
|
| PF-4708671 |
ENSG00000247498.5 |
Predicted lncRNA |
Esophageal cancer |
|
| PF-4708671 |
ENSG00000247556.2 |
Predicted lncRNA |
Sarcoma |
|
| PF-4708671 |
ENSG00000247572.3 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| PF-4708671 |
ENSG00000247595.2 |
Predicted lncRNA |
Sarcoma |
|
| PF-4708671 |
ENSG00000247934.3 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PF-4708671 |
ENSG00000247934.3 |
Predicted lncRNA |
Sarcoma |
|
| PF-4708671 |
ENSG00000247982.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PF-4708671 |
ENSG00000248138.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PF-4708671 |
ENSG00000248150.1 |
Predicted lncRNA |
Sarcoma |
|
| PF-4708671 |
ENSG00000248161.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| PF-4708671 |
ENSG00000248202.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| PF-4708671 |
ENSG00000248256.1 |
Predicted lncRNA |
Sarcoma |
|
| PF-4708671 |
ENSG00000248265.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| PF-4708671 |
ENSG00000248279.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PF-4708671 |
ENSG00000248367.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| PF-4708671 |
ENSG00000248367.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| PF-4708671 |
ENSG00000248416.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| PF-4708671 |
ENSG00000248445.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| PF-4708671 |
ENSG00000248476.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PF-4708671 |
ENSG00000248479.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PF-4708671 |
ENSG00000248515.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PF-4708671 |
ENSG00000248571.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PF-4708671 |
ENSG00000248597.1 |
Predicted lncRNA |
Esophageal cancer |
|
| PF-4708671 |
ENSG00000248714.2 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| PF-4708671 |
ENSG00000248734.2 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| PF-4708671 |
ENSG00000248734.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| PF-4708671 |
ENSG00000248758.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| PF-4708671 |
ENSG00000248790.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PF-4708671 |
ENSG00000248846.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PF-4708671 |
ENSG00000248893.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| PF-4708671 |
ENSG00000248936.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PF-4708671 |
ENSG00000248968.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| PF-4708671 |
ENSG00000248996.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| PF-4708671 |
ENSG00000249028.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| PF-4708671 |
ENSG00000249035.2 |
Predicted lncRNA |
Sarcoma |
|
| PF-4708671 |
ENSG00000249061.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PF-4708671 |
ENSG00000249084.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| PF-4708671 |
ENSG00000249094.2 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| PF-4708671 |
ENSG00000249102.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PF-4708671 |
ENSG00000249207.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| PF-4708671 |
ENSG00000249207.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PF-4708671 |
ENSG00000249207.1 |
Predicted lncRNA |
Sarcoma |
|
| PF-4708671 |
ENSG00000249252.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| PF-4708671 |
ENSG00000249304.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| PF-4708671 |
ENSG00000249306.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| PF-4708671 |
ENSG00000249328.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| PF-4708671 |
ENSG00000249345.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| PF-4708671 |
ENSG00000249379.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| PF-4708671 |
ENSG00000249395.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PF-4708671 |
ENSG00000249464.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| PF-4708671 |
ENSG00000249492.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| PF-4708671 |
ENSG00000249500.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PF-4708671 |
ENSG00000249592.1 |
Predicted lncRNA |
Sarcoma |
|
| PF-4708671 |
ENSG00000249609.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| PF-4708671 |
ENSG00000249637.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PF-4708671 |
ENSG00000249655.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| PF-4708671 |
ENSG00000249664.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| PF-4708671 |
ENSG00000249697.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| PF-4708671 |
ENSG00000249746.1 |
Predicted lncRNA |
Sarcoma |
|
| PF-4708671 |
ENSG00000249791.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| PF-4708671 |
ENSG00000249859.3 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| PF-4708671 |
ENSG00000249894.1 |
Predicted lncRNA |
Esophageal cancer |
|
| PF-4708671 |
ENSG00000249898.3 |
Predicted lncRNA |
Esophageal cancer |
|
| PF-4708671 |
ENSG00000249898.3 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PF-4708671 |
ENSG00000249942.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PF-4708671 |
ENSG00000250012.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PF-4708671 |
ENSG00000250027.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| PF-4708671 |
ENSG00000250027.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| PF-4708671 |
ENSG00000250041.2 |
Predicted lncRNA |
Esophageal cancer |
|
| PF-4708671 |
ENSG00000250057.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| PF-4708671 |
ENSG00000250057.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| PF-4708671 |
ENSG00000250075.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| PF-4708671 |
ENSG00000250075.1 |
Predicted lncRNA |
Sarcoma |
|
| PF-4708671 |
ENSG00000250116.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PF-4708671 |
ENSG00000250131.1 |
Predicted lncRNA |
Sarcoma |
|
| PF-4708671 |
ENSG00000250222.1 |
Predicted lncRNA |
Esophageal cancer |
|
| PF-4708671 |
ENSG00000250234.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| PF-4708671 |
ENSG00000250240.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| PF-4708671 |
ENSG00000250240.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| PF-4708671 |
ENSG00000250286.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PF-4708671 |
ENSG00000250312.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PF-4708671 |
ENSG00000250404.1 |
Predicted lncRNA |
Sarcoma |
|
| PF-4708671 |
ENSG00000250410.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| PF-4708671 |
ENSG00000250421.1 |
Predicted lncRNA |
Esophageal cancer |
|
| PF-4708671 |
ENSG00000250432.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| PF-4708671 |
ENSG00000250551.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| PF-4708671 |
ENSG00000250551.1 |
Predicted lncRNA |
Sarcoma |
|
| PF-4708671 |
ENSG00000250590.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| PF-4708671 |
ENSG00000250602.1 |
Predicted lncRNA |
Esophageal cancer |
|
| PF-4708671 |
ENSG00000250608.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| PF-4708671 |
ENSG00000250608.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| PF-4708671 |
ENSG00000250616.2 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| PF-4708671 |
ENSG00000250697.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PF-4708671 |
ENSG00000250802.2 |
Predicted lncRNA |
Sarcoma |
|
| PF-4708671 |
ENSG00000250900.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PF-4708671 |
ENSG00000250938.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| PF-4708671 |
ENSG00000250938.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| PF-4708671 |
ENSG00000250950.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| PF-4708671 |
ENSG00000250988.3 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| PF-4708671 |
ENSG00000251003.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| PF-4708671 |
ENSG00000251003.3 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| PF-4708671 |
ENSG00000251085.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| PF-4708671 |
ENSG00000251143.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| PF-4708671 |
ENSG00000251143.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| PF-4708671 |
ENSG00000251151.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PF-4708671 |
ENSG00000251161.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| PF-4708671 |
ENSG00000251161.2 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| PF-4708671 |
ENSG00000251175.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| PF-4708671 |
ENSG00000251179.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| PF-4708671 |
ENSG00000251191.3 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| PF-4708671 |
ENSG00000251221.1 |
Predicted lncRNA |
Esophageal cancer |
|
| PF-4708671 |
ENSG00000251230.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| PF-4708671 |
ENSG00000251279.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| PF-4708671 |
ENSG00000251279.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| PF-4708671 |
ENSG00000251281.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PF-4708671 |
ENSG00000251292.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| PF-4708671 |
ENSG00000251513.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| PF-4708671 |
ENSG00000251532.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| PF-4708671 |
ENSG00000251574.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| PF-4708671 |
ENSG00000251600.1 |
Predicted lncRNA |
Esophageal cancer |
|
| PF-4708671 |
ENSG00000253161.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PF-4708671 |
ENSG00000253167.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| PF-4708671 |
ENSG00000253167.1 |
Predicted lncRNA |
Esophageal cancer |
|
| PF-4708671 |
ENSG00000253266.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PF-4708671 |
ENSG00000253266.1 |
Predicted lncRNA |
Sarcoma |
|
| PF-4708671 |
ENSG00000253343.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| PF-4708671 |
ENSG00000253392.2 |
Predicted lncRNA |
Esophageal cancer |
|
| PF-4708671 |
ENSG00000253399.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| PF-4708671 |
ENSG00000253404.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PF-4708671 |
ENSG00000253424.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| PF-4708671 |
ENSG00000253428.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| PF-4708671 |
ENSG00000253475.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PF-4708671 |
ENSG00000253476.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| PF-4708671 |
ENSG00000253508.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PF-4708671 |
ENSG00000253526.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PF-4708671 |
ENSG00000253559.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PF-4708671 |
ENSG00000253567.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PF-4708671 |
ENSG00000253582.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| PF-4708671 |
ENSG00000253591.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| PF-4708671 |
ENSG00000253618.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| PF-4708671 |
ENSG00000253642.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| PF-4708671 |
ENSG00000253701.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PF-4708671 |
ENSG00000253712.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| PF-4708671 |
ENSG00000253716.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| PF-4708671 |
ENSG00000253746.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| PF-4708671 |
ENSG00000253746.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PF-4708671 |
ENSG00000253754.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| PF-4708671 |
ENSG00000253829.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| PF-4708671 |
ENSG00000253854.1 |
Predicted lncRNA |
Sarcoma |
|
| PF-4708671 |
ENSG00000253878.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| PF-4708671 |
ENSG00000253878.1 |
Predicted lncRNA |
Esophageal cancer |
|
| PF-4708671 |
ENSG00000253893.2 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| PF-4708671 |
ENSG00000253917.3 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| PF-4708671 |
ENSG00000253955.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| PF-4708671 |
ENSG00000253961.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| PF-4708671 |
ENSG00000254034.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| PF-4708671 |
ENSG00000254057.1 |
Predicted lncRNA |
Sarcoma |
|
| PF-4708671 |
ENSG00000254094.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| PF-4708671 |
ENSG00000254142.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PF-4708671 |
ENSG00000254165.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| PF-4708671 |
ENSG00000254166.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| PF-4708671 |
ENSG00000254204.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| PF-4708671 |
ENSG00000254211.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| PF-4708671 |
ENSG00000254226.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| PF-4708671 |
ENSG00000254226.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| PF-4708671 |
ENSG00000254238.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PF-4708671 |
ENSG00000254263.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| PF-4708671 |
ENSG00000254263.1 |
Predicted lncRNA |
Esophageal cancer |
|
| PF-4708671 |
ENSG00000254290.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PF-4708671 |
ENSG00000254295.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| PF-4708671 |
ENSG00000254315.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PF-4708671 |
ENSG00000254369.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| PF-4708671 |
ENSG00000254409.1 |
Predicted lncRNA |
Esophageal cancer |
|
| PF-4708671 |
ENSG00000254427.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| PF-4708671 |
ENSG00000254428.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| PF-4708671 |
ENSG00000254458.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| PF-4708671 |
ENSG00000254461.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| PF-4708671 |
ENSG00000254461.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PF-4708671 |
ENSG00000254468.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| PF-4708671 |
ENSG00000254538.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| PF-4708671 |
ENSG00000254604.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| PF-4708671 |
ENSG00000254689.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| PF-4708671 |
ENSG00000254691.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| PF-4708671 |
ENSG00000254699.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PF-4708671 |
ENSG00000254756.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| PF-4708671 |
ENSG00000254791.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| PF-4708671 |
ENSG00000254821.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| PF-4708671 |
ENSG00000254833.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PF-4708671 |
ENSG00000254837.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| PF-4708671 |
ENSG00000254837.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| PF-4708671 |
ENSG00000254842.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| PF-4708671 |
ENSG00000254854.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| PF-4708671 |
ENSG00000254855.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| PF-4708671 |
ENSG00000254932.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| PF-4708671 |
ENSG00000254934.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| PF-4708671 |
ENSG00000254964.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| PF-4708671 |
ENSG00000254966.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| PF-4708671 |
ENSG00000254985.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PF-4708671 |
ENSG00000254990.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| PF-4708671 |
ENSG00000255031.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PF-4708671 |
ENSG00000255050.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PF-4708671 |
ENSG00000255100.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| PF-4708671 |
ENSG00000255121.2 |
Predicted lncRNA |
Esophageal cancer |
|
| PF-4708671 |
ENSG00000255145.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| PF-4708671 |
ENSG00000255148.2 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| PF-4708671 |
ENSG00000255158.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| PF-4708671 |
ENSG00000255158.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PF-4708671 |
ENSG00000255158.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| PF-4708671 |
ENSG00000255176.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| PF-4708671 |
ENSG00000255197.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| PF-4708671 |
ENSG00000255197.1 |
Predicted lncRNA |
Sarcoma |
|
| PF-4708671 |
ENSG00000255229.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PF-4708671 |
ENSG00000255234.1 |
Predicted lncRNA |
Esophageal cancer |
|
| PF-4708671 |
ENSG00000255248.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PF-4708671 |
ENSG00000255318.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| PF-4708671 |
ENSG00000255446.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| PF-4708671 |
ENSG00000255474.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| PF-4708671 |
ENSG00000255495.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| PF-4708671 |
ENSG00000255557.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| PF-4708671 |
ENSG00000255568.2 |
Predicted lncRNA |
Esophageal cancer |
|
| PF-4708671 |
ENSG00000255571.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| PF-4708671 |
ENSG00000255650.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PF-4708671 |
ENSG00000255650.1 |
Predicted lncRNA |
Sarcoma |
|
| PF-4708671 |
ENSG00000255651.2 |
Predicted lncRNA |
Sarcoma |
|
| PF-4708671 |
ENSG00000255672.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PF-4708671 |
ENSG00000255843.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| PF-4708671 |
ENSG00000255847.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PF-4708671 |
ENSG00000255856.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PF-4708671 |
ENSG00000255857.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| PF-4708671 |
ENSG00000255867.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| PF-4708671 |
ENSG00000255928.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PF-4708671 |
ENSG00000255933.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| PF-4708671 |
ENSG00000255980.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| PF-4708671 |
ENSG00000256001.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| PF-4708671 |
ENSG00000256001.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| PF-4708671 |
ENSG00000256050.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| PF-4708671 |
ENSG00000256050.2 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| PF-4708671 |
ENSG00000256083.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PF-4708671 |
ENSG00000256128.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PF-4708671 |
ENSG00000256128.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| PF-4708671 |
ENSG00000256139.2 |
Predicted lncRNA |
Sarcoma |
|
| PF-4708671 |
ENSG00000256146.1 |
Predicted lncRNA |
Esophageal cancer |
|
| PF-4708671 |
ENSG00000256155.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| PF-4708671 |
ENSG00000256250.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| PF-4708671 |
ENSG00000256299.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| PF-4708671 |
ENSG00000256360.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| PF-4708671 |
ENSG00000256381.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| PF-4708671 |
ENSG00000256417.1 |
Predicted lncRNA |
Esophageal cancer |
|
| PF-4708671 |
ENSG00000256433.1 |
Predicted lncRNA |
Esophageal cancer |
|
| PF-4708671 |
ENSG00000256452.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| PF-4708671 |
ENSG00000256482.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| PF-4708671 |
ENSG00000256576.1 |
Predicted lncRNA |
Sarcoma |
|
| PF-4708671 |
ENSG00000256588.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| PF-4708671 |
ENSG00000256670.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| PF-4708671 |
ENSG00000256739.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| PF-4708671 |
ENSG00000256894.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| PF-4708671 |
ENSG00000256915.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| PF-4708671 |
ENSG00000256915.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PF-4708671 |
ENSG00000256973.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| PF-4708671 |
ENSG00000256973.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| PF-4708671 |
ENSG00000257023.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| PF-4708671 |
ENSG00000257027.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| PF-4708671 |
ENSG00000257083.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| PF-4708671 |
ENSG00000257114.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PF-4708671 |
ENSG00000257176.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PF-4708671 |
ENSG00000257222.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| PF-4708671 |
ENSG00000257252.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| PF-4708671 |
ENSG00000257261.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| PF-4708671 |
ENSG00000257264.2 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| PF-4708671 |
ENSG00000257270.1 |
Predicted lncRNA |
Sarcoma |
|
| PF-4708671 |
ENSG00000257298.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| PF-4708671 |
ENSG00000257354.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PF-4708671 |
ENSG00000257354.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| PF-4708671 |
ENSG00000257391.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| PF-4708671 |
ENSG00000257433.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| PF-4708671 |
ENSG00000257449.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| PF-4708671 |
ENSG00000257475.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| PF-4708671 |
ENSG00000257507.1 |
Predicted lncRNA |
Esophageal cancer |
|
| PF-4708671 |
ENSG00000257527.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| PF-4708671 |
ENSG00000257556.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| PF-4708671 |
ENSG00000257563.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| PF-4708671 |
ENSG00000257596.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| PF-4708671 |
ENSG00000257621.3 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| PF-4708671 |
ENSG00000257681.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PF-4708671 |
ENSG00000257815.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| PF-4708671 |
ENSG00000257829.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| PF-4708671 |
ENSG00000257830.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PF-4708671 |
ENSG00000257831.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| PF-4708671 |
ENSG00000257913.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| PF-4708671 |
ENSG00000257999.1 |
Predicted lncRNA |
Esophageal cancer |
|
| PF-4708671 |
ENSG00000258001.1 |
Predicted lncRNA |
Esophageal cancer |
|
| PF-4708671 |
ENSG00000258010.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| PF-4708671 |
ENSG00000258096.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| PF-4708671 |
ENSG00000258099.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PF-4708671 |
ENSG00000258101.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| PF-4708671 |
ENSG00000258175.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| PF-4708671 |
ENSG00000258279.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| PF-4708671 |
ENSG00000258303.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| PF-4708671 |
ENSG00000258354.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| PF-4708671 |
ENSG00000258410.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| PF-4708671 |
ENSG00000258410.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| PF-4708671 |
ENSG00000258414.1 |
Predicted lncRNA |
Esophageal cancer |
|
| PF-4708671 |
ENSG00000258428.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| PF-4708671 |
ENSG00000258441.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PF-4708671 |
ENSG00000258454.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PF-4708671 |
ENSG00000258454.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PF-4708671 |
ENSG00000258454.1 |
Predicted lncRNA |
Sarcoma |
|
| PF-4708671 |
ENSG00000258454.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| PF-4708671 |
ENSG00000258471.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| PF-4708671 |
ENSG00000258473.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PF-4708671 |
ENSG00000258521.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| PF-4708671 |
ENSG00000258521.1 |
Predicted lncRNA |
Sarcoma |
|
| PF-4708671 |
ENSG00000258526.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| PF-4708671 |
ENSG00000258534.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PF-4708671 |
ENSG00000258558.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PF-4708671 |
ENSG00000258561.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| PF-4708671 |
ENSG00000258623.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| PF-4708671 |
ENSG00000258646.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| PF-4708671 |
ENSG00000258658.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PF-4708671 |
ENSG00000258667.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| PF-4708671 |
ENSG00000258676.3 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| PF-4708671 |
ENSG00000258701.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| PF-4708671 |
ENSG00000258711.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PF-4708671 |
ENSG00000258725.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PF-4708671 |
ENSG00000258730.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| PF-4708671 |
ENSG00000258730.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| PF-4708671 |
ENSG00000258731.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PF-4708671 |
ENSG00000258798.1 |
Predicted lncRNA |
Sarcoma |
|
| PF-4708671 |
ENSG00000258811.1 |
Predicted lncRNA |
Esophageal cancer |
|
| PF-4708671 |
ENSG00000258813.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PF-4708671 |
ENSG00000258815.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PF-4708671 |
ENSG00000258851.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| PF-4708671 |
ENSG00000258857.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| PF-4708671 |
ENSG00000258884.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| PF-4708671 |
ENSG00000258904.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PF-4708671 |
ENSG00000258914.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PF-4708671 |
ENSG00000258920.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PF-4708671 |
ENSG00000258940.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| PF-4708671 |
ENSG00000258946.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PF-4708671 |
ENSG00000258957.1 |
Predicted lncRNA |
Esophageal cancer |
|
| PF-4708671 |
ENSG00000258982.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| PF-4708671 |
ENSG00000259062.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| PF-4708671 |
ENSG00000259062.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| PF-4708671 |
ENSG00000259065.1 |
Predicted lncRNA |
Esophageal cancer |
|
| PF-4708671 |
ENSG00000259071.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| PF-4708671 |
ENSG00000259081.1 |
Predicted lncRNA |
Esophageal cancer |
|
| PF-4708671 |
ENSG00000259083.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| PF-4708671 |
ENSG00000259115.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| PF-4708671 |
ENSG00000259116.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| PF-4708671 |
ENSG00000259125.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| PF-4708671 |
ENSG00000259125.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PF-4708671 |
ENSG00000259135.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| PF-4708671 |
ENSG00000259138.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| PF-4708671 |
ENSG00000259158.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| PF-4708671 |
ENSG00000259172.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| PF-4708671 |
ENSG00000259209.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PF-4708671 |
ENSG00000259212.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| PF-4708671 |
ENSG00000259212.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PF-4708671 |
ENSG00000259215.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PF-4708671 |
ENSG00000259225.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| PF-4708671 |
ENSG00000259230.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PF-4708671 |
ENSG00000259294.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| PF-4708671 |
ENSG00000259294.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PF-4708671 |
ENSG00000259298.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| PF-4708671 |
ENSG00000259310.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PF-4708671 |
ENSG00000259327.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PF-4708671 |
ENSG00000259336.1 |
Predicted lncRNA |
Sarcoma |
|
| PF-4708671 |
ENSG00000259342.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PF-4708671 |
ENSG00000259343.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| PF-4708671 |
ENSG00000259366.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PF-4708671 |
ENSG00000259417.2 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| PF-4708671 |
ENSG00000259422.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PF-4708671 |
ENSG00000259456.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| PF-4708671 |
ENSG00000259463.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| PF-4708671 |
ENSG00000259469.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| PF-4708671 |
ENSG00000259488.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PF-4708671 |
ENSG00000259488.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| PF-4708671 |
ENSG00000259515.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| PF-4708671 |
ENSG00000259548.1 |
Predicted lncRNA |
Sarcoma |
|
| PF-4708671 |
ENSG00000259563.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| PF-4708671 |
ENSG00000259563.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| PF-4708671 |
ENSG00000259583.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| PF-4708671 |
ENSG00000259589.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| PF-4708671 |
ENSG00000259589.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PF-4708671 |
ENSG00000259590.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| PF-4708671 |
ENSG00000259595.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| PF-4708671 |
ENSG00000259606.2 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| PF-4708671 |
ENSG00000259617.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| PF-4708671 |
ENSG00000259631.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| PF-4708671 |
ENSG00000259635.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PF-4708671 |
ENSG00000259635.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| PF-4708671 |
ENSG00000259645.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| PF-4708671 |
ENSG00000259652.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| PF-4708671 |
ENSG00000259659.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PF-4708671 |
ENSG00000259659.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| PF-4708671 |
ENSG00000259668.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PF-4708671 |
ENSG00000259668.1 |
Predicted lncRNA |
Sarcoma |
|
| PF-4708671 |
ENSG00000259687.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| PF-4708671 |
ENSG00000259712.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PF-4708671 |
ENSG00000259714.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| PF-4708671 |
ENSG00000259715.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PF-4708671 |
ENSG00000259723.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PF-4708671 |
ENSG00000259771.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| PF-4708671 |
ENSG00000259773.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| PF-4708671 |
ENSG00000259782.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| PF-4708671 |
ENSG00000259782.2 |
Predicted lncRNA |
Esophageal cancer |
|
| PF-4708671 |
ENSG00000259783.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| PF-4708671 |
ENSG00000259804.1 |
Predicted lncRNA |
Sarcoma |
|
| PF-4708671 |
ENSG00000259831.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PF-4708671 |
ENSG00000259843.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| PF-4708671 |
ENSG00000259867.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| PF-4708671 |
ENSG00000259876.1 |
Predicted lncRNA |
Sarcoma |
|
| PF-4708671 |
ENSG00000259877.1 |
Predicted lncRNA |
Esophageal cancer |
|
| PF-4708671 |
ENSG00000259877.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PF-4708671 |
ENSG00000259884.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| PF-4708671 |
ENSG00000259888.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| PF-4708671 |
ENSG00000259933.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| PF-4708671 |
ENSG00000259959.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| PF-4708671 |
ENSG00000259972.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PF-4708671 |
ENSG00000259974.2 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| PF-4708671 |
ENSG00000259994.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| PF-4708671 |
ENSG00000260032.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PF-4708671 |
ENSG00000260038.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PF-4708671 |
ENSG00000260046.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| PF-4708671 |
ENSG00000260051.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| PF-4708671 |
ENSG00000260051.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PF-4708671 |
ENSG00000260059.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PF-4708671 |
ENSG00000260086.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| PF-4708671 |
ENSG00000260086.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| PF-4708671 |
ENSG00000260093.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| PF-4708671 |
ENSG00000260145.1 |
Predicted lncRNA |
Sarcoma |
|
| PF-4708671 |
ENSG00000260162.2 |
Predicted lncRNA |
Sarcoma |
|
| PF-4708671 |
ENSG00000260196.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| PF-4708671 |
ENSG00000260196.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| PF-4708671 |
ENSG00000260248.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| PF-4708671 |
ENSG00000260252.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PF-4708671 |
ENSG00000260257.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| PF-4708671 |
ENSG00000260265.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| PF-4708671 |
ENSG00000260273.1 |
Predicted lncRNA |
Esophageal cancer |
|
| PF-4708671 |
ENSG00000260273.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| PF-4708671 |
ENSG00000260276.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| PF-4708671 |
ENSG00000260279.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PF-4708671 |
ENSG00000260293.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| PF-4708671 |
ENSG00000260310.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PF-4708671 |
ENSG00000260328.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| PF-4708671 |
ENSG00000260329.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| PF-4708671 |
ENSG00000260352.1 |
Predicted lncRNA |
Esophageal cancer |
|
| PF-4708671 |
ENSG00000260361.1 |
Predicted lncRNA |
Sarcoma |
|
| PF-4708671 |
ENSG00000260368.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| PF-4708671 |
ENSG00000260394.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PF-4708671 |
ENSG00000260396.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| PF-4708671 |
ENSG00000260400.1 |
Predicted lncRNA |
Sarcoma |
|
| PF-4708671 |
ENSG00000260400.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| PF-4708671 |
ENSG00000260475.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| PF-4708671 |
ENSG00000260488.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| PF-4708671 |
ENSG00000260509.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| PF-4708671 |
ENSG00000260510.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| PF-4708671 |
ENSG00000260517.1 |
Predicted lncRNA |
Sarcoma |
|
| PF-4708671 |
ENSG00000260528.2 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| PF-4708671 |
ENSG00000260532.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PF-4708671 |
ENSG00000260534.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| PF-4708671 |
ENSG00000260541.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| PF-4708671 |
ENSG00000260545.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| PF-4708671 |
ENSG00000260565.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| PF-4708671 |
ENSG00000260572.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| PF-4708671 |
ENSG00000260572.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| PF-4708671 |
ENSG00000260583.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| PF-4708671 |
ENSG00000260585.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PF-4708671 |
ENSG00000260588.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PF-4708671 |
ENSG00000260591.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| PF-4708671 |
ENSG00000260591.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PF-4708671 |
ENSG00000260608.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PF-4708671 |
ENSG00000260618.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| PF-4708671 |
ENSG00000260626.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| PF-4708671 |
ENSG00000260630.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| PF-4708671 |
ENSG00000260630.2 |
Predicted lncRNA |
Sarcoma |
|
| PF-4708671 |
ENSG00000260633.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| PF-4708671 |
ENSG00000260633.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| PF-4708671 |
ENSG00000260645.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| PF-4708671 |
ENSG00000260645.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PF-4708671 |
ENSG00000260650.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PF-4708671 |
ENSG00000260655.1 |
Predicted lncRNA |
Sarcoma |
|
| PF-4708671 |
ENSG00000260698.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| PF-4708671 |
ENSG00000260719.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| PF-4708671 |
ENSG00000260744.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PF-4708671 |
ENSG00000260750.1 |
Predicted lncRNA |
Sarcoma |
|
| PF-4708671 |
ENSG00000260766.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| PF-4708671 |
ENSG00000260774.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| PF-4708671 |
ENSG00000260777.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| PF-4708671 |
ENSG00000260787.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| PF-4708671 |
ENSG00000260796.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| PF-4708671 |
ENSG00000260804.2 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| PF-4708671 |
ENSG00000260807.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PF-4708671 |
ENSG00000260810.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PF-4708671 |
ENSG00000260833.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| PF-4708671 |
ENSG00000260877.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| PF-4708671 |
ENSG00000260884.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PF-4708671 |
ENSG00000260884.1 |
Predicted lncRNA |
Sarcoma |
|
| PF-4708671 |
ENSG00000260891.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PF-4708671 |
ENSG00000260910.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| PF-4708671 |
ENSG00000260927.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| PF-4708671 |
ENSG00000260927.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PF-4708671 |
ENSG00000260932.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| PF-4708671 |
ENSG00000260953.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| PF-4708671 |
ENSG00000260954.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| PF-4708671 |
ENSG00000260954.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| PF-4708671 |
ENSG00000260977.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| PF-4708671 |
ENSG00000260992.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| PF-4708671 |
ENSG00000261000.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| PF-4708671 |
ENSG00000261005.1 |
Predicted lncRNA |
Esophageal cancer |
|
| PF-4708671 |
ENSG00000261024.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| PF-4708671 |
ENSG00000261079.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PF-4708671 |
ENSG00000261094.2 |
Predicted lncRNA |
Sarcoma |
|
| PF-4708671 |
ENSG00000261105.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| PF-4708671 |
ENSG00000261114.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| PF-4708671 |
ENSG00000261123.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| PF-4708671 |
ENSG00000261124.1 |
Predicted lncRNA |
Sarcoma |
|
| PF-4708671 |
ENSG00000261126.3 |
Predicted lncRNA |
Sarcoma |
|
| PF-4708671 |
ENSG00000261159.1 |
Predicted lncRNA |
Esophageal cancer |
|
| PF-4708671 |
ENSG00000261167.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| PF-4708671 |
ENSG00000261172.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PF-4708671 |
ENSG00000261173.1 |
Predicted lncRNA |
Sarcoma |
|
| PF-4708671 |
ENSG00000261175.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| PF-4708671 |
ENSG00000261187.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| PF-4708671 |
ENSG00000261188.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| PF-4708671 |
ENSG00000261189.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| PF-4708671 |
ENSG00000261193.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| PF-4708671 |
ENSG00000261204.1 |
Predicted lncRNA |
Esophageal cancer |
|
| PF-4708671 |
ENSG00000261216.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| PF-4708671 |
ENSG00000261220.2 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| PF-4708671 |
ENSG00000261251.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| PF-4708671 |
ENSG00000261254.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| PF-4708671 |
ENSG00000261267.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PF-4708671 |
ENSG00000261267.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| PF-4708671 |
ENSG00000261270.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| PF-4708671 |
ENSG00000261280.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| PF-4708671 |
ENSG00000261280.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| PF-4708671 |
ENSG00000261326.2 |
Predicted lncRNA |
Sarcoma |
|
| PF-4708671 |
ENSG00000261327.3 |
Predicted lncRNA |
Sarcoma |
|
| PF-4708671 |
ENSG00000261334.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| PF-4708671 |
ENSG00000261334.1 |
Predicted lncRNA |
Sarcoma |
|
| PF-4708671 |
ENSG00000261337.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| PF-4708671 |
ENSG00000261337.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PF-4708671 |
ENSG00000261360.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| PF-4708671 |
ENSG00000261369.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| PF-4708671 |
ENSG00000261373.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| PF-4708671 |
ENSG00000261373.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PF-4708671 |
ENSG00000261373.1 |
Predicted lncRNA |
Sarcoma |
|
| PF-4708671 |
ENSG00000261374.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| PF-4708671 |
ENSG00000261396.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PF-4708671 |
ENSG00000261399.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| PF-4708671 |
ENSG00000261428.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| PF-4708671 |
ENSG00000261430.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| PF-4708671 |
ENSG00000261433.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| PF-4708671 |
ENSG00000261437.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| PF-4708671 |
ENSG00000261437.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| PF-4708671 |
ENSG00000261438.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PF-4708671 |
ENSG00000261438.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| PF-4708671 |
ENSG00000261442.1 |
Predicted lncRNA |
Esophageal cancer |
|
| PF-4708671 |
ENSG00000261455.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| PF-4708671 |
ENSG00000261474.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| PF-4708671 |
ENSG00000261488.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| PF-4708671 |
ENSG00000261490.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| PF-4708671 |
ENSG00000261533.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| PF-4708671 |
ENSG00000261534.1 |
Predicted lncRNA |
Sarcoma |
|
| PF-4708671 |
ENSG00000261534.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| PF-4708671 |
ENSG00000261544.1 |
Predicted lncRNA |
Esophageal cancer |
|
| PF-4708671 |
ENSG00000261544.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PF-4708671 |
ENSG00000261572.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| PF-4708671 |
ENSG00000261572.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| PF-4708671 |
ENSG00000261578.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| PF-4708671 |
ENSG00000261582.1 |
Predicted lncRNA |
Esophageal cancer |
|
| PF-4708671 |
ENSG00000261584.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PF-4708671 |
ENSG00000261592.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PF-4708671 |
ENSG00000261596.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| PF-4708671 |
ENSG00000261610.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| PF-4708671 |
ENSG00000261610.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| PF-4708671 |
ENSG00000261654.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| PF-4708671 |
ENSG00000261654.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| PF-4708671 |
ENSG00000261693.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| PF-4708671 |
ENSG00000261697.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| PF-4708671 |
ENSG00000261716.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| PF-4708671 |
ENSG00000261723.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| PF-4708671 |
ENSG00000261758.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| PF-4708671 |
ENSG00000261773.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| PF-4708671 |
ENSG00000261775.1 |
Predicted lncRNA |
Esophageal cancer |
|
| PF-4708671 |
ENSG00000261775.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| PF-4708671 |
ENSG00000261777.1 |
Predicted lncRNA |
Esophageal cancer |
|
| PF-4708671 |
ENSG00000261801.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PF-4708671 |
ENSG00000261837.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| PF-4708671 |
ENSG00000261888.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| PF-4708671 |
ENSG00000261888.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| PF-4708671 |
ENSG00000261996.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| PF-4708671 |
ENSG00000262094.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| PF-4708671 |
ENSG00000262098.1 |
Predicted lncRNA |
Sarcoma |
|
| PF-4708671 |
ENSG00000262099.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PF-4708671 |
ENSG00000262115.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PF-4708671 |
ENSG00000262136.1 |
Predicted lncRNA |
Sarcoma |
|
| PF-4708671 |
ENSG00000262172.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| PF-4708671 |
ENSG00000262265.1 |
Predicted lncRNA |
Esophageal cancer |
|
| PF-4708671 |
ENSG00000262265.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| PF-4708671 |
ENSG00000262313.1 |
Predicted lncRNA |
Sarcoma |
|
| PF-4708671 |
ENSG00000262319.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| PF-4708671 |
ENSG00000262319.1 |
Predicted lncRNA |
Sarcoma |
|
| PF-4708671 |
ENSG00000262380.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| PF-4708671 |
ENSG00000262434.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| PF-4708671 |
ENSG00000262445.3 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| PF-4708671 |
ENSG00000262454.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| PF-4708671 |
ENSG00000262454.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| PF-4708671 |
ENSG00000262468.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| PF-4708671 |
ENSG00000262468.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PF-4708671 |
ENSG00000262482.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PF-4708671 |
ENSG00000262668.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| PF-4708671 |
ENSG00000262686.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PF-4708671 |
ENSG00000262686.1 |
Predicted lncRNA |
Sarcoma |
|
| PF-4708671 |
ENSG00000262745.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| PF-4708671 |
ENSG00000262745.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PF-4708671 |
ENSG00000262772.1 |
Predicted lncRNA |
Sarcoma |
|
| PF-4708671 |
ENSG00000262777.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| PF-4708671 |
ENSG00000262837.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| PF-4708671 |
ENSG00000262873.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| PF-4708671 |
ENSG00000262873.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| PF-4708671 |
ENSG00000262877.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PF-4708671 |
ENSG00000262881.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PF-4708671 |
ENSG00000262921.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| PF-4708671 |
ENSG00000262979.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| PF-4708671 |
ENSG00000263011.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| PF-4708671 |
ENSG00000263011.1 |
Predicted lncRNA |
Esophageal cancer |
|
| PF-4708671 |
ENSG00000263011.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PF-4708671 |
ENSG00000263080.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| PF-4708671 |
ENSG00000263176.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| PF-4708671 |
ENSG00000263220.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| PF-4708671 |
ENSG00000263272.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| PF-4708671 |
ENSG00000263345.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| PF-4708671 |
ENSG00000263345.1 |
Predicted lncRNA |
Sarcoma |
|
| PF-4708671 |
ENSG00000263370.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| PF-4708671 |
ENSG00000263393.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PF-4708671 |
ENSG00000263400.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| PF-4708671 |
ENSG00000263470.1 |
Predicted lncRNA |
Sarcoma |
|
| PF-4708671 |
ENSG00000263477.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PF-4708671 |
ENSG00000263624.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| PF-4708671 |
ENSG00000263627.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| PF-4708671 |
ENSG00000263683.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| PF-4708671 |
ENSG00000263683.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| PF-4708671 |
ENSG00000263717.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| PF-4708671 |
ENSG00000263718.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| PF-4708671 |
ENSG00000263727.1 |
Predicted lncRNA |
Sarcoma |
|
| PF-4708671 |
ENSG00000263893.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PF-4708671 |
ENSG00000263982.1 |
Predicted lncRNA |
Sarcoma |
|
| PF-4708671 |
ENSG00000264043.2 |
Predicted lncRNA |
Esophageal cancer |
|
| PF-4708671 |
ENSG00000264125.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| PF-4708671 |
ENSG00000264167.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| PF-4708671 |
ENSG00000264167.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| PF-4708671 |
ENSG00000264196.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| PF-4708671 |
ENSG00000264196.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| PF-4708671 |
ENSG00000264235.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| PF-4708671 |
ENSG00000264247.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| PF-4708671 |
ENSG00000264269.1 |
Predicted lncRNA |
Sarcoma |
|
| PF-4708671 |
ENSG00000264272.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| PF-4708671 |
ENSG00000264290.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| PF-4708671 |
ENSG00000264290.1 |
Predicted lncRNA |
Sarcoma |
|
| PF-4708671 |
ENSG00000264448.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| PF-4708671 |
ENSG00000264448.2 |
Predicted lncRNA |
Sarcoma |
|
| PF-4708671 |
ENSG00000264546.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| PF-4708671 |
ENSG00000264575.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| PF-4708671 |
ENSG00000264577.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| PF-4708671 |
ENSG00000264647.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| PF-4708671 |
ENSG00000264666.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PF-4708671 |
ENSG00000264769.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| PF-4708671 |
ENSG00000264885.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PF-4708671 |
ENSG00000264920.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| PF-4708671 |
ENSG00000264964.1 |
Predicted lncRNA |
Sarcoma |
|
| PF-4708671 |
ENSG00000265008.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PF-4708671 |
ENSG00000265008.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| PF-4708671 |
ENSG00000265010.1 |
Predicted lncRNA |
Sarcoma |
|
| PF-4708671 |
ENSG00000265091.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| PF-4708671 |
ENSG00000265091.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| PF-4708671 |
ENSG00000265113.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PF-4708671 |
ENSG00000265142.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| PF-4708671 |
ENSG00000265185.2 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| PF-4708671 |
ENSG00000265205.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| PF-4708671 |
ENSG00000265334.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| PF-4708671 |
ENSG00000265349.1 |
Predicted lncRNA |
Esophageal cancer |
|
| PF-4708671 |
ENSG00000265394.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| PF-4708671 |
ENSG00000265478.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| PF-4708671 |
ENSG00000265490.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PF-4708671 |
ENSG00000265511.1 |
Predicted lncRNA |
Sarcoma |
|
| PF-4708671 |
ENSG00000265625.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PF-4708671 |
ENSG00000265717.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PF-4708671 |
ENSG00000265749.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| PF-4708671 |
ENSG00000265750.1 |
Predicted lncRNA |
Sarcoma |
|
| PF-4708671 |
ENSG00000265791.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| PF-4708671 |
ENSG00000265799.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| PF-4708671 |
ENSG00000265845.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| PF-4708671 |
ENSG00000265912.1 |
Predicted lncRNA |
Sarcoma |
|
| PF-4708671 |
ENSG00000265962.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| PF-4708671 |
ENSG00000266010.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| PF-4708671 |
ENSG00000266040.1 |
Predicted lncRNA |
Esophageal cancer |
|
| PF-4708671 |
ENSG00000266040.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PF-4708671 |
ENSG00000266079.2 |
Predicted lncRNA |
Sarcoma |
|
| PF-4708671 |
ENSG00000266126.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| PF-4708671 |
ENSG00000266289.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| PF-4708671 |
ENSG00000266411.1 |
Predicted lncRNA |
Sarcoma |
|
| PF-4708671 |
ENSG00000266445.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| PF-4708671 |
ENSG00000266456.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| PF-4708671 |
ENSG00000266466.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| PF-4708671 |
ENSG00000266498.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| PF-4708671 |
ENSG00000266498.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| PF-4708671 |
ENSG00000266541.1 |
Predicted lncRNA |
Sarcoma |
|
| PF-4708671 |
ENSG00000266604.1 |
Predicted lncRNA |
Esophageal cancer |
|
| PF-4708671 |
ENSG00000266664.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| PF-4708671 |
ENSG00000266717.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PF-4708671 |
ENSG00000266744.1 |
Predicted lncRNA |
Sarcoma |
|
| PF-4708671 |
ENSG00000266805.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| PF-4708671 |
ENSG00000266805.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PF-4708671 |
ENSG00000266821.1 |
Predicted lncRNA |
Esophageal cancer |
|
| PF-4708671 |
ENSG00000266850.1 |
Predicted lncRNA |
Sarcoma |
|
| PF-4708671 |
ENSG00000266895.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| PF-4708671 |
ENSG00000266896.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| PF-4708671 |
ENSG00000266900.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| PF-4708671 |
ENSG00000266903.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| PF-4708671 |
ENSG00000266916.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PF-4708671 |
ENSG00000266918.1 |
Predicted lncRNA |
Sarcoma |
|
| PF-4708671 |
ENSG00000266922.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| PF-4708671 |
ENSG00000266926.1 |
Predicted lncRNA |
Esophageal cancer |
|
| PF-4708671 |
ENSG00000266927.2 |
Predicted lncRNA |
Esophageal cancer |
|
| PF-4708671 |
ENSG00000266941.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| PF-4708671 |
ENSG00000266975.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| PF-4708671 |
ENSG00000267009.2 |
Predicted lncRNA |
Esophageal cancer |
|
| PF-4708671 |
ENSG00000267010.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PF-4708671 |
ENSG00000267039.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| PF-4708671 |
ENSG00000267042.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| PF-4708671 |
ENSG00000267052.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PF-4708671 |
ENSG00000267058.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PF-4708671 |
ENSG00000267064.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| PF-4708671 |
ENSG00000267064.1 |
Predicted lncRNA |
Sarcoma |
|
| PF-4708671 |
ENSG00000267067.1 |
Predicted lncRNA |
Esophageal cancer |
|
| PF-4708671 |
ENSG00000267082.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| PF-4708671 |
ENSG00000267096.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| PF-4708671 |
ENSG00000267108.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| PF-4708671 |
ENSG00000267117.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| PF-4708671 |
ENSG00000267117.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| PF-4708671 |
ENSG00000267118.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PF-4708671 |
ENSG00000267130.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PF-4708671 |
ENSG00000267138.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| PF-4708671 |
ENSG00000267161.1 |
Predicted lncRNA |
Esophageal cancer |
|
| PF-4708671 |
ENSG00000267169.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| PF-4708671 |
ENSG00000267191.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PF-4708671 |
ENSG00000267192.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| PF-4708671 |
ENSG00000267193.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| PF-4708671 |
ENSG00000267193.1 |
Predicted lncRNA |
Sarcoma |
|
| PF-4708671 |
ENSG00000267194.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| PF-4708671 |
ENSG00000267197.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| PF-4708671 |
ENSG00000267198.1 |
Predicted lncRNA |
Sarcoma |
|
| PF-4708671 |
ENSG00000267199.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| PF-4708671 |
ENSG00000267219.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| PF-4708671 |
ENSG00000267221.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| PF-4708671 |
ENSG00000267244.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PF-4708671 |
ENSG00000267246.1 |
Predicted lncRNA |
Sarcoma |
|
| PF-4708671 |
ENSG00000267248.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| PF-4708671 |
ENSG00000267249.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| PF-4708671 |
ENSG00000267265.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| PF-4708671 |
ENSG00000267272.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| PF-4708671 |
ENSG00000267273.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PF-4708671 |
ENSG00000267289.1 |
Predicted lncRNA |
Sarcoma |
|
| PF-4708671 |
ENSG00000267304.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| PF-4708671 |
ENSG00000267308.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| PF-4708671 |
ENSG00000267316.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| PF-4708671 |
ENSG00000267344.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| PF-4708671 |
ENSG00000267380.1 |
Predicted lncRNA |
Sarcoma |
|
| PF-4708671 |
ENSG00000267381.1 |
Predicted lncRNA |
Esophageal cancer |
|
| PF-4708671 |
ENSG00000267394.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| PF-4708671 |
ENSG00000267397.1 |
Predicted lncRNA |
Sarcoma |
|
| PF-4708671 |
ENSG00000267405.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| PF-4708671 |
ENSG00000267405.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| PF-4708671 |
ENSG00000267421.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| PF-4708671 |
ENSG00000267475.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| PF-4708671 |
ENSG00000267480.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| PF-4708671 |
ENSG00000267481.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| PF-4708671 |
ENSG00000267519.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| PF-4708671 |
ENSG00000267546.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| PF-4708671 |
ENSG00000267547.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| PF-4708671 |
ENSG00000267551.3 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| PF-4708671 |
ENSG00000267565.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| PF-4708671 |
ENSG00000267567.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| PF-4708671 |
ENSG00000267582.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| PF-4708671 |
ENSG00000267588.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PF-4708671 |
ENSG00000267644.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| PF-4708671 |
ENSG00000267662.1 |
Predicted lncRNA |
Sarcoma |
|
| PF-4708671 |
ENSG00000267705.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PF-4708671 |
ENSG00000267730.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| PF-4708671 |
ENSG00000267745.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| PF-4708671 |
ENSG00000267750.1 |
Predicted lncRNA |
Esophageal cancer |
|
| PF-4708671 |
ENSG00000267751.1 |
Predicted lncRNA |
Sarcoma |
|
| PF-4708671 |
ENSG00000267758.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PF-4708671 |
ENSG00000267764.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PF-4708671 |
ENSG00000267871.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| PF-4708671 |
ENSG00000267886.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PF-4708671 |
ENSG00000267898.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| PF-4708671 |
ENSG00000267919.1 |
Predicted lncRNA |
Sarcoma |
|
| PF-4708671 |
ENSG00000268066.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| PF-4708671 |
ENSG00000268087.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| PF-4708671 |
ENSG00000268189.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| PF-4708671 |
ENSG00000268201.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PF-4708671 |
ENSG00000268205.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| PF-4708671 |
ENSG00000268230.1 |
Predicted lncRNA |
Esophageal cancer |
|
| PF-4708671 |
ENSG00000268340.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| PF-4708671 |
ENSG00000268352.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PF-4708671 |
ENSG00000268366.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PF-4708671 |
ENSG00000268375.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| PF-4708671 |
ENSG00000268401.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| PF-4708671 |
ENSG00000268520.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| PF-4708671 |
ENSG00000268543.1 |
Predicted lncRNA |
Esophageal cancer |
|
| PF-4708671 |
ENSG00000268564.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| PF-4708671 |
ENSG00000268584.1 |
Predicted lncRNA |
Esophageal cancer |
|
| PF-4708671 |
ENSG00000268601.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| PF-4708671 |
ENSG00000268686.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| PF-4708671 |
ENSG00000268707.1 |
Predicted lncRNA |
Sarcoma |
|
| PF-4708671 |
ENSG00000268836.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| PF-4708671 |
ENSG00000268913.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| PF-4708671 |
ENSG00000268931.1 |
Predicted lncRNA |
Esophageal cancer |
|
| PF-4708671 |
ENSG00000269019.1 |
Predicted lncRNA |
Sarcoma |
|
| PF-4708671 |
ENSG00000269037.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PF-4708671 |
ENSG00000269044.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| PF-4708671 |
ENSG00000269066.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| PF-4708671 |
ENSG00000269086.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PF-4708671 |
ENSG00000269091.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| PF-4708671 |
ENSG00000269191.1 |
Predicted lncRNA |
Sarcoma |
|
| PF-4708671 |
ENSG00000269202.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| PF-4708671 |
ENSG00000269289.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PF-4708671 |
ENSG00000269321.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| PF-4708671 |
ENSG00000269386.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| PF-4708671 |
ENSG00000269397.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PF-4708671 |
ENSG00000269425.1 |
Predicted lncRNA |
Sarcoma |
|
| PF-4708671 |
ENSG00000269463.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| PF-4708671 |
ENSG00000269483.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| PF-4708671 |
ENSG00000269486.1 |
Predicted lncRNA |
Esophageal cancer |
|
| PF-4708671 |
ENSG00000269489.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| PF-4708671 |
ENSG00000269652.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| PF-4708671 |
ENSG00000269737.1 |
Predicted lncRNA |
Sarcoma |
|
| PF-4708671 |
ENSG00000269815.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| PF-4708671 |
ENSG00000269887.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| PF-4708671 |
ENSG00000269893.2 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| PF-4708671 |
ENSG00000269894.1 |
Predicted lncRNA |
Sarcoma |
|
| PF-4708671 |
ENSG00000269896.1 |
Predicted lncRNA |
Esophageal cancer |
|
| PF-4708671 |
ENSG00000269902.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PF-4708671 |
ENSG00000269906.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| PF-4708671 |
ENSG00000269923.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| PF-4708671 |
ENSG00000269925.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| PF-4708671 |
ENSG00000269938.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| PF-4708671 |
ENSG00000269938.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| PF-4708671 |
ENSG00000269942.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| PF-4708671 |
ENSG00000269942.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| PF-4708671 |
ENSG00000269942.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| PF-4708671 |
ENSG00000269951.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PF-4708671 |
ENSG00000269959.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| PF-4708671 |
ENSG00000269973.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| PF-4708671 |
ENSG00000269979.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| PF-4708671 |
ENSG00000269979.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PF-4708671 |
ENSG00000269990.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| PF-4708671 |
ENSG00000269994.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| PF-4708671 |
ENSG00000269997.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| PF-4708671 |
ENSG00000269997.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PF-4708671 |
ENSG00000269999.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PF-4708671 |
ENSG00000270001.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| PF-4708671 |
ENSG00000270006.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| PF-4708671 |
ENSG00000270009.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| PF-4708671 |
ENSG00000270012.1 |
Predicted lncRNA |
Sarcoma |
|
| PF-4708671 |
ENSG00000270020.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| PF-4708671 |
ENSG00000270028.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| PF-4708671 |
ENSG00000270031.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| PF-4708671 |
ENSG00000270031.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| PF-4708671 |
ENSG00000270036.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| PF-4708671 |
ENSG00000270039.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| PF-4708671 |
ENSG00000270055.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PF-4708671 |
ENSG00000270060.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PF-4708671 |
ENSG00000270061.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| PF-4708671 |
ENSG00000270061.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PF-4708671 |
ENSG00000270072.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| PF-4708671 |
ENSG00000270095.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PF-4708671 |
ENSG00000270100.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| PF-4708671 |
ENSG00000270108.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PF-4708671 |
ENSG00000270115.1 |
Predicted lncRNA |
Sarcoma |
|
| PF-4708671 |
ENSG00000270124.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| PF-4708671 |
ENSG00000270168.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| PF-4708671 |
ENSG00000270170.1 |
Predicted lncRNA |
Esophageal cancer |
|
| PF-4708671 |
ENSG00000270174.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PF-4708671 |
ENSG00000270184.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PF-4708671 |
ENSG00000270189.1 |
Predicted lncRNA |
Sarcoma |
|
| PF-4708671 |
ENSG00000270190.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| PF-4708671 |
ENSG00000270223.1 |
Predicted lncRNA |
Sarcoma |
|
| PF-4708671 |
ENSG00000270332.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| PF-4708671 |
ENSG00000270346.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| PF-4708671 |
ENSG00000270419.1 |
Predicted lncRNA |
Esophageal cancer |
|
| PF-4708671 |
ENSG00000270482.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| PF-4708671 |
ENSG00000270589.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| PF-4708671 |
ENSG00000270589.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PF-4708671 |
ENSG00000270605.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| PF-4708671 |
ENSG00000270605.1 |
Predicted lncRNA |
Sarcoma |
|
| PF-4708671 |
ENSG00000270607.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PF-4708671 |
ENSG00000270755.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| PF-4708671 |
ENSG00000270933.1 |
Predicted lncRNA |
Esophageal cancer |
|
| PF-4708671 |
ENSG00000270933.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| PF-4708671 |
ENSG00000270964.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PF-4708671 |
ENSG00000270996.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| PF-4708671 |
ENSG00000271109.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PF-4708671 |
ENSG00000271119.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| PF-4708671 |
ENSG00000271185.1 |
Predicted lncRNA |
Sarcoma |
|
| PF-4708671 |
ENSG00000271199.1 |
Predicted lncRNA |
Sarcoma |
|
| PF-4708671 |
ENSG00000271228.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| PF-4708671 |
ENSG00000271314.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| PF-4708671 |
ENSG00000271327.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| PF-4708671 |
ENSG00000271359.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| PF-4708671 |
ENSG00000271390.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PF-4708671 |
ENSG00000271427.1 |
Predicted lncRNA |
Esophageal cancer |
|
| PF-4708671 |
ENSG00000271553.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| PF-4708671 |
ENSG00000271555.1 |
Predicted lncRNA |
Sarcoma |
|
| PF-4708671 |
ENSG00000271584.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PF-4708671 |
ENSG00000271646.1 |
Predicted lncRNA |
Esophageal cancer |
|
| PF-4708671 |
ENSG00000271659.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| PF-4708671 |
ENSG00000271715.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| PF-4708671 |
ENSG00000271727.1 |
Predicted lncRNA |
Esophageal cancer |
|
| PF-4708671 |
ENSG00000271732.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| PF-4708671 |
ENSG00000271734.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| PF-4708671 |
ENSG00000271734.1 |
Predicted lncRNA |
Sarcoma |
|
| PF-4708671 |
ENSG00000271757.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| PF-4708671 |
ENSG00000271757.1 |
Predicted lncRNA |
Sarcoma |
|
| PF-4708671 |
ENSG00000271761.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| PF-4708671 |
ENSG00000271778.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| PF-4708671 |
ENSG00000271815.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| PF-4708671 |
ENSG00000271816.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PF-4708671 |
ENSG00000271835.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| PF-4708671 |
ENSG00000271843.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| PF-4708671 |
ENSG00000271843.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| PF-4708671 |
ENSG00000271857.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| PF-4708671 |
ENSG00000271874.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| PF-4708671 |
ENSG00000271874.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| PF-4708671 |
ENSG00000271938.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PF-4708671 |
ENSG00000271947.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| PF-4708671 |
ENSG00000271964.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| PF-4708671 |
ENSG00000271971.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| PF-4708671 |
ENSG00000271971.1 |
Predicted lncRNA |
Sarcoma |
|
| PF-4708671 |
ENSG00000271978.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| PF-4708671 |
ENSG00000271983.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| PF-4708671 |
ENSG00000271991.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| PF-4708671 |
ENSG00000271993.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| PF-4708671 |
ENSG00000272003.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| PF-4708671 |
ENSG00000272023.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| PF-4708671 |
ENSG00000272023.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| PF-4708671 |
ENSG00000272024.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| PF-4708671 |
ENSG00000272029.1 |
Predicted lncRNA |
Sarcoma |
|
| PF-4708671 |
ENSG00000272033.1 |
Predicted lncRNA |
Esophageal cancer |
|
| PF-4708671 |
ENSG00000272033.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PF-4708671 |
ENSG00000272048.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| PF-4708671 |
ENSG00000272068.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| PF-4708671 |
ENSG00000272079.1 |
Predicted lncRNA |
Esophageal cancer |
|
| PF-4708671 |
ENSG00000272079.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| PF-4708671 |
ENSG00000272087.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| PF-4708671 |
ENSG00000272091.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| PF-4708671 |
ENSG00000272092.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| PF-4708671 |
ENSG00000272102.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| PF-4708671 |
ENSG00000272102.1 |
Predicted lncRNA |
Sarcoma |
|
| PF-4708671 |
ENSG00000272130.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| PF-4708671 |
ENSG00000272140.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PF-4708671 |
ENSG00000272141.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| PF-4708671 |
ENSG00000272146.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| PF-4708671 |
ENSG00000272146.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| PF-4708671 |
ENSG00000272146.1 |
Predicted lncRNA |
Sarcoma |
|
| PF-4708671 |
ENSG00000272148.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| PF-4708671 |
ENSG00000272158.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| PF-4708671 |
ENSG00000272181.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PF-4708671 |
ENSG00000272191.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| PF-4708671 |
ENSG00000272192.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| PF-4708671 |
ENSG00000272198.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| PF-4708671 |
ENSG00000272198.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| PF-4708671 |
ENSG00000272211.1 |
Predicted lncRNA |
Esophageal cancer |
|
| PF-4708671 |
ENSG00000272216.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PF-4708671 |
ENSG00000272219.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| PF-4708671 |
ENSG00000272221.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| PF-4708671 |
ENSG00000272233.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| PF-4708671 |
ENSG00000272243.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PF-4708671 |
ENSG00000272248.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| PF-4708671 |
ENSG00000272255.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| PF-4708671 |
ENSG00000272255.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| PF-4708671 |
ENSG00000272263.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| PF-4708671 |
ENSG00000272275.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| PF-4708671 |
ENSG00000272301.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| PF-4708671 |
ENSG00000272308.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| PF-4708671 |
ENSG00000272312.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| PF-4708671 |
ENSG00000272335.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| PF-4708671 |
ENSG00000272341.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| PF-4708671 |
ENSG00000272343.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| PF-4708671 |
ENSG00000272368.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| PF-4708671 |
ENSG00000272374.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| PF-4708671 |
ENSG00000272374.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PF-4708671 |
ENSG00000272403.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| PF-4708671 |
ENSG00000272417.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| PF-4708671 |
ENSG00000272425.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| PF-4708671 |
ENSG00000272438.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PF-4708671 |
ENSG00000272444.1 |
Predicted lncRNA |
Esophageal cancer |
|
| PF-4708671 |
ENSG00000272446.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| PF-4708671 |
ENSG00000272449.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| PF-4708671 |
ENSG00000272452.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| PF-4708671 |
ENSG00000272455.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| PF-4708671 |
ENSG00000272472.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| PF-4708671 |
ENSG00000272483.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| PF-4708671 |
ENSG00000272508.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| PF-4708671 |
ENSG00000272523.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| PF-4708671 |
ENSG00000272529.1 |
Predicted lncRNA |
Esophageal cancer |
|
| PF-4708671 |
ENSG00000272563.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PF-4708671 |
ENSG00000272566.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PF-4708671 |
ENSG00000272620.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PF-4708671 |
ENSG00000272627.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PF-4708671 |
ENSG00000272646.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| PF-4708671 |
ENSG00000272659.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| PF-4708671 |
ENSG00000272662.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| PF-4708671 |
ENSG00000272667.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| PF-4708671 |
ENSG00000272689.1 |
Predicted lncRNA |
Sarcoma |
|
| PF-4708671 |
ENSG00000272692.1 |
Predicted lncRNA |
Esophageal cancer |
|
| PF-4708671 |
ENSG00000272695.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| PF-4708671 |
ENSG00000272707.1 |
Predicted lncRNA |
Esophageal cancer |
|
| PF-4708671 |
ENSG00000272709.1 |
Predicted lncRNA |
Esophageal cancer |
|
| PF-4708671 |
ENSG00000272720.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PF-4708671 |
ENSG00000272745.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| PF-4708671 |
ENSG00000272755.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| PF-4708671 |
ENSG00000272758.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PF-4708671 |
ENSG00000272763.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| PF-4708671 |
ENSG00000272782.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| PF-4708671 |
ENSG00000272783.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PF-4708671 |
ENSG00000272796.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| PF-4708671 |
ENSG00000272800.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PF-4708671 |
ENSG00000272810.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| PF-4708671 |
ENSG00000272812.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PF-4708671 |
ENSG00000272834.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| PF-4708671 |
ENSG00000272836.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| PF-4708671 |
ENSG00000272848.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| PF-4708671 |
ENSG00000272849.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| PF-4708671 |
ENSG00000272866.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| PF-4708671 |
ENSG00000272871.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| PF-4708671 |
ENSG00000272885.1 |
Predicted lncRNA |
Sarcoma |
|
| PF-4708671 |
ENSG00000272892.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| PF-4708671 |
ENSG00000272913.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| PF-4708671 |
ENSG00000272954.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| PF-4708671 |
ENSG00000272983.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| PF-4708671 |
ENSG00000272993.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| PF-4708671 |
ENSG00000273001.1 |
Predicted lncRNA |
Sarcoma |
|
| PF-4708671 |
ENSG00000273004.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| PF-4708671 |
ENSG00000273027.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| PF-4708671 |
ENSG00000273027.1 |
Predicted lncRNA |
Esophageal cancer |
|
| PF-4708671 |
ENSG00000273056.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PF-4708671 |
ENSG00000273058.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| PF-4708671 |
ENSG00000273065.1 |
Predicted lncRNA |
Sarcoma |
|
| PF-4708671 |
ENSG00000273071.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| PF-4708671 |
ENSG00000273076.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PF-4708671 |
ENSG00000273081.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| PF-4708671 |
ENSG00000273096.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| PF-4708671 |
ENSG00000273102.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| PF-4708671 |
ENSG00000273133.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| PF-4708671 |
ENSG00000273137.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| PF-4708671 |
ENSG00000273142.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| PF-4708671 |
ENSG00000273145.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PF-4708671 |
ENSG00000273156.1 |
Predicted lncRNA |
Sarcoma |
|
| PF-4708671 |
ENSG00000273160.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| PF-4708671 |
ENSG00000273174.1 |
Predicted lncRNA |
Esophageal cancer |
|
| PF-4708671 |
ENSG00000273183.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PF-4708671 |
ENSG00000273203.1 |
Predicted lncRNA |
Esophageal cancer |
|
| PF-4708671 |
ENSG00000273237.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| PF-4708671 |
ENSG00000273248.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| PF-4708671 |
ENSG00000273257.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| PF-4708671 |
ENSG00000273264.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| PF-4708671 |
ENSG00000273271.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| PF-4708671 |
ENSG00000273281.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| PF-4708671 |
ENSG00000273284.1 |
Predicted lncRNA |
Sarcoma |
|
| PF-4708671 |
ENSG00000273287.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| PF-4708671 |
ENSG00000273293.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| PF-4708671 |
ENSG00000273329.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| PF-4708671 |
ENSG00000273343.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| PF-4708671 |
ENSG00000273348.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PF-4708671 |
ENSG00000273350.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| PF-4708671 |
ENSG00000273355.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| PF-4708671 |
ENSG00000273365.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PF-4708671 |
ENSG00000273372.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| PF-4708671 |
ENSG00000273374.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| PF-4708671 |
ENSG00000273375.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| PF-4708671 |
ENSG00000273424.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| PF-4708671 |
ENSG00000273428.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| PF-4708671 |
ENSG00000273448.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| PF-4708671 |
ENSG00000273451.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| PF-4708671 |
ENSG00000273456.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| PF-4708671 |
ENSG00000273483.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| PF-4708671 |
ENSG00000273488.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
